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twijfelen of de antitumor werking van bleomyciine het resultaat is 
van uitsluitend DNA destructie. 
• R.S. Magliozzo, J. Peisach and M.R. Ciriolo, Mol. Pharmacol. 
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2) Bij het onderzoek naar de praktische toepassing van witlof-
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besteed worden aan de onderlinge omzettingen van de bittere 
Sesquiterpeen lactonen. 
3) In de verklaring die Schneider et al. geven voor de fragmentatie 
van bepaalde monogetosyleerde steroidale 1,3-diolen wordt ten 
onrechte voorbij gegaan aan 'through-bond' interacties, die kunnen 
optreden na deprotonering van de hydroxyl groep. 
• G. Schneider, S. Bottka, L. Hackler, J. Wolfling and P. Sohâr, 
Liebigs Ann. Chem. 1989, 263. 
4) De argumenten waarop Aoyama et al. de struktuurtoekenning van de 
atroopisomeren 5,15-bis(8-chinolyl)octaethylporphyrinen baseren, 
zijn zwak. 
• Y. Aoyama, T. Kamohara, A. Yamagishi, H. Toi and H. Ogoshi, 
Tetrahedron Letters, 1987, 28, 2143. 
5) Het bijprodukt, dat ontstaat bij 'flash vacuum thermolysis' van 
3-phenyl-4,5-dihydroisoxazole-5-spirocyclobutane is niet 
l-benzoyl-2-methylenepyrollidine, zoals Goti et al. beweren, maar 
(l-phenylethenyl)-2-pyrollidine. 
• A. Goti, A. Brandi, F. De Sarlo and A. Guarna, Tetrahedron 
Letters, 1986, 27, 5271. 
6) De wijze waarop Goldsby en Burke tot de struktuurtoekenning van 
een uit Ambrosia peruviana geïsoleerde sesquiterpeen diol komen, 
is aanvechtbaar. 
• G. Goldsby and B.A. Burke, Phytochemistry, 1987, 26, 1059. 
7) Het rookverbod in openbare ruimten van rijksgebouwen is zonder 
controle net zo gedoemd te mislukken als het verbod om harder dan 
120 km per uur te rijden op rijkswegen. 
8) Het is opvallend dat de aanduiding 'mw' voor een vrouw in offi-
ciële stukken vaker wordt gebruikt dan het equivalente 'dhr' voor 
een man. Hieruit zou men kunnen concluderen dat de schrijvers niet 
echt begaan zijn met het bereiken van gelijkheid tussen mannen en 
vrouwen. 
Wageningen, 2 mei 1990 
Belal Shadid 
CHAPTER I 
GENERAL INTRODUCTION 
Plants normally grow and develop in an orderly, organized way. This is one of the many 
characteristics they share with all living organisms. Such orderly growth and development may 
be affected in many ways by the environment, which in some cases plays a very important part 
in controlling or triggering off various patterns of development. For example, some plants only 
produce flowers if the daily light period exceeds a certain critical length, and some will only do so 
if they have been exposed to cold at an early stage in their development. 
In a general way however, it is obvious that the essential features of growth and development 
are built into the genetic constitution of the plant and are thus controlled from within. The 
internal control of growth is achieved in many and complex ways. 
One of the important growth-controlling systems in plants is provided by the so-called plant 
growth substances or plant hormones. Plant hormones differ from animal hormones in a 
number of ways. Perhaps the most important difference is that animal hormones are produced 
in specific organs or glands and often have very highly specific effects. Plants hormones, on the 
other hand, though they may be produced in fairly restricted regions of plants, are manufactured 
by unspecialized cells and frequently have many different effects upon the plant, depending 
upon other circumstances. A plant hormone is an organic substance which is produced within a 
plant. At low concentrations it will promote, inhibit or qualitatively modify growth, usually at a 
site other than its place of origin. Its effect does not depend upon its calorific value or its content 
of essential elements1. 
Studies of the chemistry and the physiological activities of naturally occurring plant growth 
hormones have revealed that three major classes of growth-promoting hormones exist in plants. 
These are called auxins, cytokinins and gibberellins (see fig. 1.1). This thesis deals with the 
chemistry of cytokinins. 
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Fig.1.1 : Examples ot each of three classes of plant growth hormones are: 1 . indolacetic 
acid (an auxin);2, zeatin (a cytokinin): 3,gibberillin A3 (agibberillin). 
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CYTOKININS 
The cytokinins, a group of naturally occuring compounds which induce plant cell division2'3 
are N6-substituted derivatives of adenine (4, Fig. 1.2). The modern era of research on the 
cytokinins began in 1955 with the isolation of kinetin from old DNA of herring sperm, by Miller 
et al4'5, and was found to be a highly potent growth factor. This group, working at the University 
of Wisconsin named this product kinetin, because of its promotion of cytokinesis (cell division) 
in tobacco callus tissue and characterized6 it as 6-furfurylaminopurine (5, fig. 1.2). As the synthetic 
6-benzylaminopurine (6, fig. 1.2) and many other N6-substituted adenine derivatives also 
produce this result, the class name cytokinin was proposed and applied to the group as a whole7. 
Since the isolation of kinetin in 1955, there have been many reports of the diverse effects of 
cytokinins on plants. Evidence has accumulated for their role in the following8-10: 
1. induction, promotion, or regulation of DNA, RNA, protein, and thiamine biosynthesis. 
2. regulation of organ formation, apical dominance, and branching. 
3. enhancement of flowering and of seed germination. 
4. regulation of phloem transport and mobilization of metabolites. 
5. preservation of flowers, fruits, vegetables, and leaves through prevention of senescence. 
Certain cytokinins have also been shown to effect the behavior of mammalian cells. They 
have been reported to regulate the growth of mammalian cells11"13, to inhibit platelet 
aggregation14, and to have immunosuppressive activity15. Cytokinins have also been employed 
as potential anticancer agents in clinical trials16"19. 
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A. OCCURRENCE OF CYTOKININS IN NATURE 
Kinetin (6, fig. 1.2) was the first compound to be discovered as a stimulator of cell division in 
plants. Because of the biological effect of kinetin on the growth of plants, it was suggested that a 
compound closely resembling to kinetin was present in plants. In 1964 Letham20 and his 
associates characterized such an active factor for plant growth from young sweetcorn kernels and 
named it zeatin (from the generic name for corn, zeamays). They characterized it as 6-(4-hydroxy-
3-methyl-E-but-2-enylamino)purine (2, fig. 1.1). 
Since that time a large number of cytokinins has been isolated in free form or as a component 
of tRNA from bacteria, yeast, plants and animals3-21"25 (see fig. 1.3). All these compounds contain 
the skeleton of 6-(3-methyl-2-butenylamino)purine (7, fig. 1.3) but feature one of the following 
modifications: 
1. a hydroxy group on the methyl group of the side chain (cis/trans) 
2. a saturated instead of a A2 double bond 
3. a substituent at N9 (ribosyl, ribosyl-5'-phosphate, glucosyl or alanyl) 
4. replacement of the hydrogen by a thiomethyl group at C2' position in the purine ring . 
B. CYTOKININS AND NUCLEIC ACID 
Unique among the plant growth substances is the well documented localization of cytokinins 
in nucleic acid. Different laboratories with very different directions of research came upon this 
phenomenon. Until recently, each nucleic acid (fig. 1.4) was thought to be composed of four 
nucleoside structures. This view has changed markedly in the last years and at present about 10 
deoxyribonucleosides and about 40 ribonucleosides have been identified26. Modified nucleosides 
occur in DNA, rRNA and tRNA. Most progress has been made with studies on tRNA. Because of 
their structural variety, it is impossible to treat the modified nucleosides as a single class of 
nucleic acid components. 
Some of these modified nucleosides which occur in t RNA of most if not all organisms27"31, 
are identified as the cytokinins N6-(A2-isopentenyl)adenosine i.e. 6-(3-methyl-2-butenylamino)-9-
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(ß-D-ribofuranosyl)purine (8, fig.1.3), 6-(4-hydroxy-3-methyl-Z-but-2-enylamino)-9-(ß-D-ribo-
furanosyDpurine (18, fig. 1.3) and 6-(4-hydroxy-3-methyl-Z-but-2-enylamino)-2-thiomethyl-9-(ß-
D-ribofuranosyl)purine (19, fig. 1.3). 
Sequencing of several tRNA's has shown cytokinin-active nucleosides to be present exclusive-
ly in the position adjacent to the 3' end of the anticodon triplet32"43 (the sequence of bases, which 
carries the matching code for the messenger RNA (mRNA), which in turn specifies the proper 
place for the amino acid in the protein. Many workers in this field suggested that the presence of 
the cytokinins in some tRNA's is essential for the function of this nucleic acid3-26'44"47. 
HO OH 
primary structure of RNA 
Fig. 1.4 
C. THE BIOLOGICAL SYNTHESIS OF CYTOKININS IN PLANTS 
Since the discovery that naturally occurring cytokinins are typically N6-substituted adenine 
derivatives, that several highly active species have been isolated at the purine, ribonucleoside, 
ribonucleotide, glucoside and alanylated levels (free cytokinins) and that cytokinins are present 
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Scheme 1.6 
as a component of tRNA (tRNA bound cytokinins), there is continued discussion about the 
biosynthesis of cytokinins. At this moment success is realized in the understanding of the 
biosynthesis of tRNA bound cytokinins26'45'47"55. The isoprenoid nature of the substituent at the 
N6-position of the naturally occurring cytokinins suggests that the biosynthesis of these com-
pounds may parallel, to some extent, the biosynthesis of sterols and other terpenoid compounds. 
A central compound in this pathway is mevalonic acid (25, scheme 1.5), which functions as 
precurser of A2-isopentenyl pyrophosphate (28, scheme 1.5). With the enzym tRNA-A2-isopen-
tenyltransferase as biocatalyst, 28 reacts with the amino group of the adenine moiety in tRNA. 
Only those adenosine residues in tRNA, which do not contain an isopentenyl group and are 
adjacent to the 3' end of the anticodon-triplet, can accept te isopentenyl group. Further 
modification, such as hydroxylation of the allylic methyl group, or introduction of the 
thiomethyl group at the C2' position on the purine, gives the RNA bound cytokinins. 
The biosynthesis of free cytokinins in plants is not clear and is subject to discussion. At this 
moment there are three hypotheses for the biological synthesis of the free cytokinins (see scheme 
1.6). The first hypothesis62"64 is the synthesis of the free cytokinins by the breakdown of tRNA, 
which contains cytokinins to yield the free cytokinins. The second hypothesis56"61 is the synthesis 
of free cytokinins by the reaction of adenosine 5'-phosphate (5'AMP) (29, scheme 1.6) with A2-
isopentenyl pyrophosphate (28) to give A2-isopentenyladenosine 5'-phosphate (30). This reaction 
is catalyzed by the enzym 5'-AMP-A2-isopentenyltransferase. The third hypothesis is a 
combination of the first and the second hypothesis65. Convincing experimental data to confirm 
any of these hypotheses are lacking66. 
D. THE CHEMICAL SYNTHESIS OF CYTOKININS 
To a large extent it was the already advanced knowledge in purine chemistry which permitted 
the characterization of the naturally occurring cytokinins. The characterization has relied very 
heavily on application of physical methods, particulary mass spectrometry and ultraviolet 
spectroscopy. 
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Scheme 1.7: The common synthetic method for cytokinins. The reactions 
with an amine and 6-chloropurine derivative may proceed with R' equal 
to hydrogen or some other substituent. 
The important final step in the identification of the natural product was the synthesis of the 
compound with the proposed structure and direct comparison with the natural product. 
Therefore, syntheses of the known naturally occurring cytokinins are described in the literature. 
From the study of this literature, we came to the conclusion that in some cases the synthetic 
methods described in the literature could be improved. 
It is not the object of this thesis to provide a complete survey of the various methods 
employed in the synthesis of cytokinins. The general strategy67"88 for the synthesis of cytokinins 
is illustrated in scheme 1.7. It involves the reaction of 6-chloropurine derivative 31 with the 
appropriate amine. In this thesis our attention is focussed on the synthesis of phosphorylated, 
and alanylated cytokinins, which shall be discussed in chapter II. 
This synthetic study was part of a program of cooperation between our laboratory and the 
Centre of Agricultural and Biological Research at Wageningen, which Centre is directed to study 
the mechanism of action, metabolism, translocation, uptake, the biological synthesis and the 
physiological effects of cytokinins in plants89"93. 
This study is directed towards the synthesis of two different classes of cytokinins: 
A. the synthesis of phosphorylated cytokinins: 
1. the synthesis of phosphorylated derivatives of zeatin 
2. the synthesis of phosphorylated derivatives of zeatin ribofuranoside 
3. the synthesis of phosphorylated isopentenyl adenine 
B. the synthesis of alanylated cytokinins: 
the synthesis of the optically active N9-alanyl zeatin (D and L lupinic acid). 
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CHAPTER II 
INTRODUCTION TO THE SYNTHESIS OF PHOSPHORYLATED AND ALANYLATED 
CYTOKININS 
A. PHOSPORYLATED CYTOKININS 
As indicated in chapter I, the introduction of the phosphate group and its modification in 
naturally occurring cytokinins is the major subject of this thesis. So far a number of chemical 
procedures have been reported which have been proven to be suitable for the synthesis of 5'-
phosphorylated cytokinins (3 and 8, see scheme II.l and II.3). 
H O — P — O 
O O 
4 5 
Scheme II.1 
One of the first reported syntheses of the phosphorylated cytokinin N6-(A2-isopentenyl)-
adenosine 5'-phosphate (3, scheme II.l) has been achieved by two different routes1-2. The first 
13 
route1 involves alkylation of adenosine 5-phosphate 1 with A2-isopentenylbromide to give N1-
isopentenyl adenosinium salt 2, and a subsequent Dimroth rearrangement of 2 into 3 by 
treatment with NaOH. This method, however, has two disadvantages. First, the over-all yield of 
compound 3 is low (19%), because the yield of the alkylation step(l -> 2) is only 28% and 
secondly, the presence of unreacted adenosine 5'-phosphate 1 makes the purification of the 
product difficult. 
The second route2 for the synthesis of 3 (see scheme II.1) is based on the phosphorylation of 
the properly protected N6-(A2-isopentenyl)adenosine derivative 4 with POCI3, followed by the 
cleavage of the protective isopropylidene group under acidic conditions to give 3 in 40% yield. 
The disadvantage of this method is the use of the powerful phosphorylating agent POC13, which 
leads to the formation of side products as illustrated in scheme II.2 
The formation of side products makes the purification procedure difficult and leads to a low 
yield of the desired product. 
0 0 0 
1) POCI3 II II II 
R-OH R—O—P—OH + R—O—P—OR + R—O—P—OR 
2) H 2 0 | | | 
OH OH OR 
Scheme II.2 
The synthesis of another phosphorylated cytokinin i.e. 6-(4-hydroxy-3-methyl-2-
butenylamino)-9-ß-D-ribofuranosylpurine 5'-phosphate (8, scheme II.3) was achieved by the 
phosphorylation of 6-chloro-9-((2',3'-0-isopropylidene)-ß-D-ribofuranosyl)purine 6 with POCI3 
followed by the cleavage of the protective isopropylidene group under acidic conditions to afford 
6-chloro-9-(ß-D-ribofuranosyl)purine 5'-phosphate 7 (yield 30%)3. The coupling of 7 with trans 4-
amino-2-methyl-2-buten-l-ol (reagent B) gives 8 in 16% yield besides an unidentified 
phosphorylated cytokinin. 
This method also has two disadvantages. First, the use of POCI3 leads to the formation of side 
products resulting in a low yield of the desired product and making the purification of the 
procedure difficult. Secondly, the coupling of the aminoalcohol (reagent B) with 7 in basic 
conditions leads to a shift of the phosphate group at the 5'-position to the 3'-position at the 
ribofuranosyl side. 
Show et al3'4 attempted the synthesis of the allylic phosphates of cytokinins 9 and 10 (fig. II, 1). 
A first attempt4 (see scheme II.4) to the synthesis of 9 i.e. by treatment of 6-(4-hydroxy-3-methyl-E-
but-2-enylamino)-9-(2',3'-0-isopropylidene-ß-D-ribofuranosyl)purine 11 with POCI3, and 
14 
o 
1) POCI3 I I 
HO—P-2) OH" 
3) H + OH 
reagent B 
H CH2OH 
\ / 
reagent B ^ c = c 
/ \ 
H2N—CH2 CH3 
/ KHCO3 . H20 
Scheme II.3 
subsequent removal of the isopropylidene group under acidic conditions, did not result in the 
formation of diphosphate (9, fig. II.1). Only the monophosphate 12 (scheme II.4), was obtained, 
suggesting that under this condition the allylic phosphate if formed is readily hydrolyzed. 
O—P—OH 
OH 
O 
II 
H CH 2 —O—P—OH \ / I 
C = C OH / \ 
1 0 
Fig. II.1 
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3) H+ 
HO OH 
1 2 
Scheme II.4 
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Scheme II.5 
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The second attempt3 to the synthesis of 9 and 10 by Shaw et al. was made by using the 
phosphorylation of the isopropylidene ribofuranosyl derivative 13, (scheme II.5) with 2-cyano-
ethyl phosphate and dicyclohexylcarbodiimide in pyridine. The formation of the allylic 
pyridinium derivative 15, however, implies that during the phosphorylation of the 
isopropylidene derivative 13 in pyridine both the 5'- and the allylic hydroxy groups are 
phosphorylated. The allylic phosphate, being a sufficiently powerful leaving group is replaced by 
the pyridine. Similarly the allylic pyridinium salt 16 was obtained by the phosphorylation of 
zeatin 14 using the same procedure as described above3. 
It has now become clear that up till now there was no effective high-yield method for the 
synthesis of cytokinin phosphates. In this thesis we will describe a succesful approach to 
synthesize cytokinin phosphates avoiding the problems mentioned above. This succes was 
realized first by using an efficient way for the preparation of properly protected cytokinins and 
secondly by developing new methods for the introduction of phosphate groups in the cytokinins. 
Two approaches, i.e. the phosphatetriester5-6 (scheme II.6) and the 1-H-phosphonatediester7-8 
(scheme II.7) have been used. 
The design of the bifunctional phosphorylating reagent 189, (scheme II.6) obtained by reaction 
of the morpholinodichlorophosphate with l-hydroxy(6-trifluoromethyl)benzotriazole 17 was an 
important breakthrough in the development of the phosphatetriester procedure. 
Reagent 18 reacted with the primary hydroxy function (R-OH) to afford intermediate 20. 
This was followed by the hydrolysis of the l-(6-trifluoromethyl)benzotriazolyl and the 
morpholino groups to give the required phosphate 22. This phosphatetriester approach was 
successfully used in the synthesis10 of 39 and 40 (fig. II, 2). 
Despite the broad scope of phosphate triester method11"20 the preparation of the allylic phosphate 
26 appeared to be impossible when applying this methodology. A solution for this problem was 
found in the 1-H-phosphonatediester approach, which is illustrated in scheme II. 7 The 
introduction of the easily accessible monofunctional phosphitylating reagent salicyl-
chlorophosphite22 24 enabled us to prepare the H-phosphonate monoester 26 via intermediate 
25. Reaction of 26 with N,0-bis(trimethylsilyl)acetamide gave intermediate 27. Treatment of 27 
with powdered sulfur gave after hydrolysis the thiophosphate 28. Reaction of 27 with 2,2'-
dipyridyldisulfide gave intermediate 29, which on hydrolysis with water gave the 
monophosphate 30. Methanolysis of 29 with methanol gave methylphosphate 31, while 
treatment of 29 with morpholine gave the phosphoroamidate 32. Compound 32 when reacted 
with H3PO4 gave pyrophosphate 33. 
This 1-H-phosphonatediester approach was succesfully used for the synthesis of all 
cytokininphosphates23"26, which contain allylic phosphates or pyrophosphate (see fig. II. 2). 
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I 
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 F3C 
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Scheme II.6 
B: THE SYNTHESIS OF OPTICALLY ACTIVE ALANYLATED CYTOKININS 
The chemical synthesis of a racemic mixture of D,L-lupinic acid is described in the literature27. 
However, pure L-lupinic acid L-49 and D-lupinic acid D-49 (fig. ll.3)have never been prepared 
Only the enzymatic formation of L-49 from trans-zeatin 50 and O-acetyl-L-serine, using as 
enzyme source extracts of Lupinus seedlings has been reported28. Attemps29 to prepare L-49 by a 
pyridcxal 5'-phosphate (PLP)-catalyzed reaction between 50 and O-acetyl-L-serine met with little 
success (yield about 1.5%). 
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Fig II.3 
Our approach (see scheme II 8) for the synthesis of L-lupinic acid L-49 and D-lupinic acid D-49 
is based on the stereospecific hydrolysis of D,L-lupinic acid amide 51 by using the L-specific 
aminopeptidase from Pseudomonas putida30-31, to afford L-lupinic acid L-49 and D-lupinic acid 
amide D-51. Hydrolysis of D-51 under mild acidic conditions affords D-lupinic acid D-49. 
L-specific 
aminopeptidase 
CH2CH(NH2)CONH2 
D.L-51 
H CH2OH \ / 
R = C = C / \ 
H2N—CH2 CH3 
L-49 D-51 
Scheme II.8 
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CHAPTER III 
PHOSPHORYLATION OF ALLYLIC HYDROXY GROUPS VIA PHOSPHITE INTERMEDIATES 
At present, two distinct approaches have been developed for the chemical phosphorylation of an 
allylic hydroxy group. In one approach1* (see scheme III.l), which is based on a procedure 
originally devised by Cramer et al? for the preparation of allylic pyrophosphate esters, the allylic 
hydroxyl in geraniol 1 was activated with trichloroacetonitrile in the presence of sodium hydride 
to give intermediate 2. Displacement of the trichloroacetimidate group by ortho-phosphoric acid 
then affords the monophosphate 3. This pathway is unfortunately accompanied by the formation 
of the rearrangement product 4 which makes the isolation of 3 rather laborious. The other 
approach3 (see scheme III.l) consists of a base-assisted (2,6-dimethylpyridine) phosphorylation of 
I with ortho-phenylene phosphorochloridate4 to give 5. Hydrolysis of 5. in the presence of the 
same base, yields 6 which is then deblocked with lead (IV) acetate to afford 3. The advantage of 
this phosphotriester method is the absence of rearrangement product 4 however, the final 
deblocking step gives rese to the formation of coloured by-products. 
The above mentioned problems inherent in the synthesis of allylic monophosphates could be 
circumvented by using phosphorylating reagents (reagent D and reagent E, see scheme III.2) 
recently developed for the preparation of nucleic acid derivatives. In order to examine this 
possibility, 4-hydroxy-3-methyl-E-but-2-enylphthalimide5 (7, 1.0 mmol) in dioxane (5 ml) was 
treated with the afunctional phosphorylating reagent (reagent D)6 (1.2 mmol) in the presence of 
4(N,N-dimethylamino) pyridine (1.2 mmol). TLC-analysis (silica gel), after lh at 20°C, showed 
the absence of 7 and the presence of a new product with high mobility. Work-up and purification 
by short-column chromatography7 gave a homogeneous non-phosphorus containing compound 
(yield 85%). *H-, 13C-, 19F-NMR and mass spectroscopic data of this compound were in accord 
with structure 8. The exclusive formatio of 8 implies that the intermediate formed triester is, in 
contrast with the corresponding non-allylic triesters, displaced by the released trifluoromethyl 
benzotriazoxide. In this respect it is also interesting to note that the formation of 8 is comparible 
with the rapid quaternisation of an allylic phosphate diester by pyridine9. The observation that 
allylic phosphate di- and tri-esters are still powerful leaving groups urged us to find out whether 
1-H-phosphonate mono-esters would be less prone to substitution. To this end, compound 7 (1.0 
mmol) in dioxane (5 ml) was phosphitylated with the monofunctional reagent (reagent E)10 (1.4 
mmol) in the presence of N,N-diisopropylethylamine (1.5 mmol). TLC-analysis, after 5 min, 
showed complete conversion of 7 into phosphite triester 9. Hydrolysis of the latter intermediate 
followed by work-up and purification afforded 10, which was isolated as the Na+-salt (8p 5.59, Jp-H 
620 Hz), in a yield of 85%. The 1-H-phosphonate ester 10 could easily be converted into the 
phosphate mono ester 12 by a slight modification of the procedure of Hâta et a/.11. Thus silylation 
of 10 with N,0-bis (trimethylsilyl)acetamide gave the intermediate bis (trimethylsilyl) phosphite 
II (8p 119.76 ppm). In situ oxidation of 11 with 2,2'-dipyridyl disulfide (reagent K) (1.2 mmol) was 
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complete within 1 h as evidenced by the formation of an S-pyridyl-O-trimethylsilyl allyl 
phosphorothioate derivative (5p 9.70 ppm). Hydrolysis of the latter intermediate, subsequent 
work-up, after 2 h, and purification (DEAE Sephadex A25) yielded homogeneous 12 (yield 80%, 
Na+-salt, 8p 2.33 ppm). 
In conclusion, the results presented in this paper show that salicylchlorophosphite (reagent E) is 
a promising convenient reagent for the preparation of allylic 1-H-phosphonates which, in turn, 
can be easily oxidized to give the corresponding mono-phosphates. Further, preliminary 
experiments indicated that the intermediate obtained after treating 11 with (reagent K) could also 
be applied towards the synthesis of phosphorothioate and pyrophosphate derivatives of 7. 
EXPERIMENTAL 
General procedures. 
N,N-diisopropylethylamine and dioxane were dried by refuxing with CaH2 for 16 h and then 
distilled. Dioxane was redistilled from LiAlH4 (5g/l). All liqiuds were stored under nitrogen. 
N,0-bis(trimethylsilyl)acetamide and 2,2'-dipyridyldisulfide were purchased from Janssen 
Chimica (Belgium). 4-hydroxy-3-methyl-E-but-2-enylphtalimide5 , 2-chloro-4H-l,3,2-
b e n z o d i o x a p h o s p h o r i n - 4 - o n e 1 ° a n d N - m o r p h o l i n o 0 , 0 - b i s [ ( 6 -
trifluoromethyl)benzotriazolyl]phosphate12 were prepared as described previously. 
Triethylammonium bicarbonate buffer was prepared by passing a stream of CO2 gas through a 
cooled (ice-water bath) 2M solution of triethylamine in deionzed water until solution became 
neutral. Schleicher and Schuil DC Fertigfolien F 1500 LS 254 v/ere used for TLC. The following 
solvent system were used. System A (dichloromethane/methanol, 96:4, v,v), system B 
(dichloromethane/methanol, 80:20, v/v). Short column chromatography was performed on 
silicagel 60 (230-400 mesh ASTM) suspended in dichloromethane. DEAE Spehadex A25 was 
purched from Pharmacia (Uppsala, Sweden). Cation-exchange resin (Na+-form): a solution of 
NaOH (2M; 100 ml) was passed over a column packed with cation-exchange resin (Dowex 50 Wx-
8, 100-200 mesh; Fluka H+-form, 1.5 x 5 cm) followed by washing of the column with sterile water 
until pH - 7. iH-NMR spectra were measured at 200 MHz using a JEOL JNM-FX 200 
spectrometer. 13C-NMR spectra weremeasured at 50.4 MHz using a JEOL JNM-FX 200 
spectrometer; Proton noise decoupling was used. 19F-NMR spectrum was measured at 282.4 MHz 
using a Bruker WM-300 spectrometer 31P-NMR spectra were measured at 80.7 MHz, using a 
JEOL JNM-FX 200 spectrometer. Chemical shifts are in ppm relative to 85% H3PO4 as external 
standard. Mass spectrum of 8 was measured using a AEI MS 902 spetrometer equipped with a VG 
ZAB console. 
Synthesis of 4-trifluoromethylbertzotriazolyl-3-methyl-E-but-2-enylphtalimidide 8 
A solu t ion of phosphory la t ing agent N - m o r p h o l i n o - 0 , 0 - b i s [ ( 6 -
triflucromethyl)benzotriazolyl]phosphate (reagent D) in dioxane (0.2 M, 6.0 ml, 1.2 mmol) was 
added to 4-hydro;cy-3-methyl-E-but-2-enylphtalimide 7 (0.23 g, 2.0 mmol) which was 
coevaporated with dioxane (3 x 10 ml) and disolved in dioxane (5 ml), 4(N,N-
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dimethylamino)pyridine (0.26 g, 1.2 mmol) was added. After 1 h at 20°C TLC analysis (system A) 
showed the absence of 7 and the formation of a new compound with Rf = 0.60. The reaction 
mixture was diluted with dichloromethane (100 ml) and the resulting solution was washed twice 
with triethylammonium bicarbonate buffer (IM, 50 ml, 0.1M, 50 ml). The organic layers were 
combined and dried on MgSÜ4, concentrated to an oil, which was chromatographed on a column 
of silicagel.Elution with CH2CI2/CH3OH (100 : 0 -» 98 : 2, v/v) gave after evaporation pure 8 as a 
white solid. Yield 0.35 g (85%), Rf = 0.60 (system A). 
Compound 8; !H-NMR (CDCI3, 200 MHz, 5-values are given in ppm): 7.80 (m, 7 x ArH), 5.55 (t, J 
6.0 Hz, H2), 4.97 (s, 2 x H4), 4.23 (d, J 7.0 Hz, 2 x Hi), 2.16 (s, 3x MeH); 13C-NMR (CDCI3, 50.4 MHz, 
ö-values are given in ppm): 167.4 (2 x O O ) , 139.6 (C3), 133.9, 132.7, 131.6, 127.9, 123.1, 121.0,107.0 
and 66.9 (11 x ArC), 121.1 (C2), 86.1 (C4), 34.9 (Ci), 14.5 (Me); «F-NMR (CFCI3, 282.4 MHz, 6-values 
are given in ppm): -62.10; Mass spectrum: found m/e 416.1094, calc. for C2oHi5F3N4C>3: 416.1096. 
Synthesis of 4-(l-Hphosphonate)-3-methyl-E-but-2-enylphtalimide 10 
To a solution of 4-hydroxy-3-methyl-E-but-2-enylphtalimide 7 (0.23 g, 1.0 mmol) and N,N-
diisopropylethylamine (0.28 ml, 1.5 mmol) in dioxane 10 ml was added 2-chloro-4H-l,3,2-
benzodioxaphosphorin-4-one (reagent E) (0.28 g, 1.4 mmol). After reaction for 5 min. at 20 °C, it 
was found by TLC analysis (system A) that complete conversion of starting compound into a 
product with zeromobility has taken place. Water was added (1 ml) and the solution was left for 
10 min. at 20 °C. The reaction solution was concentrated to a small volume and triturated with 
diethylether, the precipitated oil was dissolved in water and applied to a column of DEAE 
Sephadex A25 (HCC>3"-form) suspended in triethylammonium bicarbonate buffer (0.05M). The 
column was eluted with a linear gradient of triethylammonium bicarbonate buffer (0.05-»0.50 M) 
for 16 h with a flow rate 35 ml/h, and fractions of 10 ml were collected. All UV-positive eluates 
containing 10, Rf = 0 (system B), were pooled and concentrated to a small volume, coevaporation 
with water (4 x 50 ml). Then the solution was applied to a column of Dowex 50 WX-8 cation-
exhange resin (Na+-form, 1.5 x 5 cm).The column was eluted with water and all UV-positieve 
eluates were collected and concentrated to a small volume. Lyophilization from D2O gave 10 as 
white solid yield 0.27 g (85%). 
Compound 10; ]H-NMR (D20): 7.58 (m, 4 x ArK), 6.77 (d, J 631.6 Hz, PH), 5.49 (t, J 5.8 Hz,H2), 4.28 
(d, J 9.1 Hz, 2 x H4), 4.09 (d, J 7.2 Hz, 2 x Hi), 1.83 (s, 3 x MeH): 13C-NMR (D20): 171.8 (2 x C O ) , 
139.6 (d, ] 7.3 Hz, C3), 137.3,133.4 and 125.8 (6 x ArC), 122.4 (C2), 70.9 (d, J 4.4 Hz, C4), 37.8 ( d ) , 15.9 
(Me); 31P-NMR (D20): 5p = 5.59 ppm, Jp.H 620 Hz. 
Synthesis of 4-phosphate-3-methyl-E-but-2-enylphtalimide 12. 
The Na+-salt of 10 (0.26 g, 0.82 mmol) was repeatedly coevaporated with dioxane (4 x 10 ml). The 
residue was diluted with dioxane (5 ml) and this mixture was treated with N,N-
diisopropylethylamine (0.30 ml, 1,64 mmol) and N,0-bis(trimethylsilyl)acetamide (0.41 ml, 1.64 
mmol) after 15 min. 31P-NMR analysis of the solution indicated the complete conversion of 10 
into 11, (5p 5.59 ppm - 119.76 ppm). The reaction solution was further treated with 2,2'-dipyridyl 
disulfide (0.26 g, 1.2 mmol) for 1 h. After 1 h the 31P-NMR absorption at 119.76 ppm was 
completely disappeard and 31P-NMR spectrum features a new peak at 9.70 ppm indicating that 
the conversion of 11 is complete. Then water was added (3 ml) and the solution was applied left 
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for 2h at 20 °C. The solution was concentrated to an oil which was applied to a column of DEAE-
Sephadex in triethylammonium bicarbonate buffer (0.05 M). The column was eluted with a 
linear gradient of triethylammonium buffer (0.05 —» 0.50 M) for 15 h with a flow rate of 35 ml/h 
and fractions of 10 ml were collected. The UV-positive eluates containing 12, Rf = 0 (system B) 
were pooled and concentrated to a small volumn, coevaporated with water (4 x 50 ml). Then the 
solution was applied to a column of Dowex 50 Wx-8 cation-exhange resin (Na+-form, 1.5 x 5 cm). 
The column was eluted with water and all UV positive eluates were collected and concentrated 
to a small volume lyophilization from D2O gave 12 as white solid. Yield 0.23 g (80%). 
Compound 12 ; !H-NMR (D20): 7.55 (m, 4 x ArH), 5.46 (t, J 5.7 Hz, H2), 4.22 (d, J 5.8 Hz, 2 x H4), 
4.11 (d, J 8.8 Hz, 2 x Hi), 1.80 (s, 3 x MeH); 13C-NMR (D20): 170.4 (2 x C=0), 138.6 (d, J 7.3 Hz, C3), 
135.6,132.2 and 124.1 (6 x ArC), 119.9 (C2), 70.0 (d, J 4.4 Hz, C4), 36.2 ( d ) , 14.0 (Me); 31P-NMR (D20): 
Sp -- 2.33 ppm. 
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CHAPTER IV 
THE SYNTHESIS OF ALLYLIC PHOSPHATE DERIVATIVES OF TRANS ZEATIN 
INTRODUCTION 
Progress in biochemical research during recent years has clearly pointed out the unique 
importance of cytokinins in biological systems. The cytckinins, a group of naturally occurring 
compounds which induce plant cell division, are N-6-substituted derivatives of adenine, which 
may occur as a free-base, as its ribonucleoside or ribonucleotide. 
The first naturally occurring plantgrowth substance with pronounced cell division induction 
was isolated in pure form from immature sweetcorn kernels1. This compound was assigned 
structure Z\, based on UV, NMR and Mass spectral data, enzymatic characterisation as well as 
independent synthesis. 
Attempts were made to synthesize the allylic phosphate of zeatin i.e. Z2, from Zi by using the 
powerful phosphorylating pyrophosphoryl chloride, or by applying a mixture of 2-cyanoethyl 
phosphate and dicyclohexylcarbodiimide in pyridine. Both attempts failed2. It has been reported3 
that phosphorylation of polyprenols, containing an allylic hydroxy group, by a reaction between 
the active intermediate polyprenol trichloroimidates and anhydrous orthophosphoric acid, was 
successful, but that in this reaction also rearranged products are obtained. 
Recently a new and efficient method for the phosphorylation of an allylic hydroxy group via a 
phosphite intermediate has been found4. This method is based on the phosphitylation of an 
allylic hydroxy group with salicyl chlorophosphite and oxidation of the allylic phosphonate 
monoester, being formed to the corresponding phosphate monoester. Application of this 
phosphitetriester-approach was already demonstrated in the preparation of phosphonate and 
phosphate monoesters of N-(4-hydroxy-3-methyl-E-but-2-enyl) phthalimide (see chapter III). 
We will now report in detail the synthesis of the allylic phosphonate Z5, the methylphosphate 
Z3, and the thiophosphate Z4 of (ran.s-zeatin 2,\. 
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RESULTS AND DISCUSSION 
The strategy we have adopted for the synthesis of these allylic phosphate derivatives of zeatin 
consisted of the following steps: i. the synthesis of frans-zeatin protected at N-9 with a 
tetrahydropyranyl (THP)group i.e. 3; ii. the synthesis of N-9-protected rrans-zeatin phosphonate 
5; iii. the conversion of 5 into the corresponding phosphate, methylphosphate or thiophosphate 
7, 8 and 9 respectively; iv. the removal of the N-9-protecting group (see scheme IV.1). 
Our approach to the synthesis of the N-9-THP frans-zeatin 3 is a modification of two syntheses, 
being already reported. N-(4-acetoxy-3-methyl-E-but-2-enyl) phthalimide 1, being prepared by a 
procedure described before6, was converted in a one-pot reaction into E-4-amino-2-methyl-2-
buten-1-ol (2) (yield 85%) by treatment with 85% aqueous hydrazine (removal of the phthaloyl 
group) and subsequent heating with hydrochloric acid (hydrolysis of the Ecetoxy group). 
Coupling of 2 with 6-chloro-N-9-THP purine7 (reagent A) in refluxing butanol in the presence of 
triethylamine gave N-9-THP rraws-zeatin 3 (yield 76%). Protection of the N-9-pcsition by the 
tetrahydropyranyl group was necessary to avoid side-reactions during the phosphitylation 
reaction. The protective THP group can later be removed under mild acidic conditions8. The next 
step is the synthesis of N-9-THP-frans-zeatin phosphonate 5, being the key intermediate in the 
synthesis of the allylic phosphate derivatives Z2, Z3, Z4, and Z5. Treatment of N-9-THP-frans-
zeatin 3 in dioxane with the monofunctional reagent 2-chloro-4H-l, 3, 2-benzodioxaphosphorin-
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4-one (reagent B, 1.4 equiv.) in the presence of N, N-diisopropylethylamine (1.4 equiv.) for 5 min 
gave phosphite triester 4, which was hydrolyzed into 5 being isolated as Na+-salt in a yield of 
85%. By ! H NMR, 13C NMR and 31P NMR data (see experimental part) its structure was proven. 
The oxidation of N-9-trans zeatin phosphonate 5 into N-9-THP-frans-zeatin phosphate 7 was 
[performed according to a slight modification of the procedure of Hâta et al9. Thus, 1 equiv. of 5 in 
idioxane was treated with N, O-bis (trimethylsilyl) acetamide (reagent C, 2 equiv.) in the presence 
iof N, N-diisopropylethylamine (2 equiv.) for 15 min. to give intermediate bis (trimethylsilyl) 
phosphite (6). Without further purification 6 was treated with 1.2 equiv. of 2,2'-dipyridyldisulfide 
(reagent D) for lh, and the reaction mixture obtained was subsequently treated with water, 
yielding 7. Treatment of 6 with 2/2'-dipyridyldisulfide (reagent D) in the presnece of dry 
methanol (8 equiv.) gave N-9-THP-trans zeatin methylphosphate 8. 
Sulfurization of 6 with powdered sulfur for 15 h and subsequent treatment with water gave N-9-
THP-frans-zeatin phosphorothioate 9. The cleavage of the ,acid-labile-THP-group in the 
phosphate derivatives 5, 7, 8 and 9 was effected by acid treatment at pH=2 for 3 h. After work-up 
frans-zeatin phosphonate Zs, frans-zeatin phosphate Z2, frans-zeatin methylphosphate Z3 and 
frflws-zeatin thiophosphate Z4 were obtained. Over-all yield of these phosphate derivatives 
fluctuated between 70% and 83% as calculated from N-9-THP frans-zeatin 3. 
The identity of frans-zeatin allylic phosphate derivatives Z2, Z3, Z4 and Z5 was ascertained by JH 
NMR, 13C NMR and 31P NMR-spectroscopy (see Experimental Part). The lH NMR and 13C NMR 
data of these compounds in D2O are almost identical with those of frans-zeatin Zi 1 0 ' 1 1 with 
exception of the ^-absorption of CH2-O which in zeatin is found as singlet at 3.8 ppm., and in 
the zeatin derivatives Z2, Z3, Z4 and Z5 as a doublet at about 4.2 ppm., caused by the coupling of 
1H with 31P(3JH-p). 
In the 13C NMR-spectra, the difference between zeatin and its phosphate derivatives is obvious 
in the absorption of CH2O and CH3Ç=C. The 13C-signal of the CH2O group appears in zeatin (Zi) 
as a singlet at 67 ppm. but in the zeatin phosphate derivatives (Z2-Z5) a doublet or a broad singlet 
at about 70 ppm is observed. The 13C singlet of CH3Ç=C at about 137 ppm. in Z\ becomes a 
doublet in the zeatin phosphate derivatives (Z2-Z5). The doublets are caused by the coupling of 
13C with 31P(2Jc-P and 3Jc-p)- The range of the coupling depends on the structure of the 
compound1 2 . Proton decoupled 3 1P NMR spectroscopy revealed the presence of only one 
resonance absorption which further evidences the structural identity and purity of the 
compounds. 
From these results it can be unequivocally concluded that the method described above is a fast, 
simple and reliable procedure for the preparation of zeatin phosphate derivatives. These 
rompounds are produced in satisfactory yields without the formation of any side-products. 
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EXPERIMENTAL 
General procedures. 
N, N-diisopropylethylamine, dioxane, triethylamine were dried by refluxing with CaH2 for 16 h 
and then distilled. Dioxane was redistilled from UAIH4 (5 g/1). Methanol was dried by refluxing 
with magnesium methoxide and distilled before use. All liquids were stored under nitrogen. 
N,0-bis(trimethylsilyl)acetamide and 2,2-dipyridyldisulfide were purchased from Janssen 
Chimica (Belgium). N-9-(tetrahydro-2-pyranyl)-6-chloropurine and 2-chloro-4H-l,3,2-
benzodioxaphosphorin-4-one were prepared as described previously7'13. Triethylammonium 
bicarbonat buffer was prepared by passing a stream of CO2 gas through a cooled (ice-water bath) 
2M solution of triethylamine in deionized water until solution became neutral. Schleicher and 
Schuil DC Fertigfclien Fl 1500 LS 254 were used for TLC. The following solvent systems were 
used: System A (chloroform/methanol, 85:15, v/v), system B (chloroform/methanol, 80:20, v/v), 
system C (isopropyl alcohol/concentrated ammonium hydroxide/water, 7:1:2, v/v). 
Short column chromatography was performed on silicagel 60 (230-400 mesh A STM) suspended 
in CH2CI2, or on Sephadex LH 20 suspended in CH2CI2/CH3OH (2:1, v/v), unless otherwise 
mentioned. DEAE Sephadex A 25 was purchased from Pharmacia (Uppsala, Sweden). Cation-
exchange resin (Na+-form): a solution of NaOH (2M; 100 ml) was passed over a column packed 
with cation-exchange resin (Dowex 50 Wx-8, 100-200 mesh; Flüka H+-form, 1.5x5 cm) followed by 
washing of the column with sterile water until pH=7. Sterile water and glass were used during 
the whole deblocking and purification processes. 
!H NMR spectra were measured at 300 MHz using a Bruker CXP 300 spectrometer. 13C NMR 
spectra were measured at 75.460 MHz using a Bruker CXP 300 spectrometer; Proton noise 
decoupling was used. 31P NMR spectra were measured at 121.470 MHz using a Bruker CXP 300 
spectrometer, chemical shifts are in ppm relative to 85% H3PO4 as external standard. Mass 
spectrum of 3 was measured using a AEI MS 902 spectrometer equipped with a VG ZAB console. 
Synthesis of (E)-4-amino-2-methyl-2-buten-l-ol 2 
A mixture of N-(4-acetoxy-3-methyl-E-but-2-enyl) phthalimide 1 (3.30 g, 14.12 mmol), 85% 
aqueous hydrazine hydrate solution (0.85 ml, 14.14 mmol) and methanol (100 ml) was refluxed 
for 1 h with stirring. TLC analysis (system A) indicated complete conversion of the starting 
material into a product having Rf=0. After cooling of the solution water (8.7 ml) and cone, 
hydrochloric acid (8.7 ml) were added and the reaction mixture was heated under reflux for 1 h. 
After cooling to 0 C the phthalylhydrazide was removed by filtration and the filtrate was 
evaporated at 30°C in a rotary evaporator. Then the residue was dissolved in water (20 ml) and 
the insoluble material was removed by filtration. The filtrate was brought to pH=10 with 4N 
aqueous sodium hydroxide solution. The resulting solution was continuously extracted with 
chloroform. The organic extract was dried (MgSC>4) to give after evaporation the aminoalcohol 2. 
Yield 1.21 gram (85%), oil, ^H NMR-spectrum was identical to that described in the literature6. 
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Synthesis of N-9-(tetrahydro-2-pyranyl)-f/-flns-zeatin 3 
A mixture of aminoalcohol 2 (1.21 g, 12 mmol), N-9-(tetrahydro-2-pyranyl)-6-chloropurine-(2.38 
g, 10 mmol), anhydrous triethylamine (1.43 ml) and n-butanol (150 ml) was boiled under reflux 
for 3 h. TLC analysis (system A) indicated complete conversion of starting material. The reaction 
solution was concentrated under reduced pressure to an oil, which was chromatographed on a 
column of silicagel. Elution with CH2CI2/CH3OH (100:0 -> 98:2, v/v) gave after evaporation 2.3 g 
(76%) of 3, oil, Rf=0.72 (system A). 
Compound 3, JH NMR (CDCI3): S = 8.32, s, 1H, H-8; 7.91, s, 1H, H-2; 6.55, t, J = 5.16 Hz, 1H, CH2-
NH; 5.62, m, 2H, CH = C and 1H (THP); 4.22-4.06, m, 4H, CH2-N, OH and 1H (THP); 3.90, s, 2H, 
CH2-O; 3.72, m, 1H, 1H (THP); 2.05 - 1.92, m, 3H, 3H (THP); 1.67 - 1.58, m, 3H, 3H (THP); 1.60, s, 
3H, CH3; 13c NMR: (CDCI3): 5 = 154.5, s, C6; 153.2, s, C2; 148.1, s, Q ; 139.9, s, C8; 137.2, s, CH3-Ç = C; 
120.1, s, CT = C; 119.3, s, C5; 81.6, 69.7, 67.1, 24.8 and 22.7 5 x s,(THP); 67.1, s, CH2-OH; 31.8, s, CH2-
N; 13.8, s, CH3; HRMS, found m/z 303.1703, Ci5H2 iN502 requires 303.1695. 
Synthesis of N-9-(tetrahydro-2-pyranyl)-fr«ns-zeatin phosphonate 5 
To a solution of N-9-(tetrahydro-2-pyranyl)-£rans-zeatin 3 (0.30 g, 1 mmol) and N, N-
diisopropylethylamine (0.26 ml, 1.4 mmol) in dioxane (10 ml) was added 2-chloro-4H-l,3,2-
benzodioxaphosphorin-4-one (0.28 g, 1.4 mmol). After reaction for 5 min at 20°C, it was found by 
TLC analysis (system A) that complete conversion of starting compound into a product with 
zeromobility has taken place. Water was added (1 ml) and the solution was left for 10 min at 
20°C. The reaction solution was concentrated to a small volume and triturated with diethylether, 
the precipitated oil (crude 5) was dissolved in water and applied to a column of DEAE Sephadex 
A 25 (HCC>3-form) suspended in triethylammonium bicarbonate buffer (0.05 M). 
The column was eluted with a linear gradient of triethylammonium bicarbonate buffer (0.05 —» 
0.70 M) for 16 h with a flow rate of 35 ml/h, and fractions of 6 ml were collected. All UV-positive 
eluates, containing purine product Rf = 0 (system B), Rf = 0.75 (system C), were pooled and 
concentrated to a small volume; coevaporation with water (4 x 50 ml) removed most of 
triethylammonium bicarbonate. Then the solution was applied to a column of Dowex 50 Wx-8 
cation-exchange resin (Na+-form, 1.5 x 5 cm). The column was eluted with water and all UV-
positive eluates were collected and concentrated to a small volume. Lyophilization from D 2 0 
gave 5 as white solid. Yield 0.33 g (85%), Rf = 0.73 (system C). 
Compound 5, lH NMR (D20): 5 = 7.89, s, 1H, H-8; 7.84, s, 1H, H-2; 6.60, d, lJH-p = 634.5 Hz, 1H, P-
H; 5.44, m, 1H, 1H (THP); 5.27, t, J = 7.2 Hz, 1H, CH = C; 4.12, d, 3jH_P = 7.8 Hz, 2H, CH2-0-P; 3.84, 
m, 3H, CH2-N and 1H (THP); 3.56, m, 2H, 2H (THP); 1.82, s, 3H, CH3; 1.49, m, 5H, 5H (THP); ™C 
NMR (D20) : 6 = 154.7, s, C6; 153.2, s, C2; 148.0, s, Q ; 137.3, s, C8; 136.5, d, 3jC-p= 7.3 Hz, CH3-Ç = C; 
123.4, s, CH = C; 119.4, s, C5; 82.6, 67.4,30.5,25.10 and 23.0 5x s, (THP); 69.5, d, 2JC-p = 7.3 Hz, CH2-0-
P; 39.3, s, CH2-N; 14.1, s, CH3; 31 p NMR (D20); 5p = 5.59 ppm, (l]H-p = 620 Hz). 
Synthesis of fraws-zeatin phosphate Z? 
Crude 5 (synthesized from 1 mmol of 3) was coevaporated with dioxane and dissolved in 
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dioxane (10 ml). The solution was treated with N, N-diisopropylethylamine (0.35 ml, 2 mmol) 
and N, O-bis(trimethylsilyl) acetamide (0.5 ml, 2 mmol). After 15 min, 3 1P NMR analysis of the 
solution indicated the complete conversion of 5 into 6, (Sp = 6.8 ppm —> 118 ppm). The reaction 
solution was further treated with 2,2'-dipyridyldisulfide (0.26 g, 1.2 mmol) for one hour. After 1 
hr the 31P NMR absorption at 118 ppm was completely disappeared and the 31P-spectrum 
features a new peak at 5p = 9.8 ppm indicating that the conversion of 6 is complete (solution A). 
Then water was added (3 ml) and the solution was applied left for 2 h at 20°C. The solution was 
concentrated to an oil which was applied to a column of DEAE-Sephadex A 25 (HC03-form) 
suspended in triethylammonium bicarbonate buffer (0.05 M). 
The column was eluted with a linear gradient of triethylammonium bicarbonate buffer (0.05 -
0.7 M) for 18 h with a flow rate of 35 ml/h. Fractions of 10 ml were collected, and all UV-positive 
eluates, containing purine product 714, [Rf = 0 (system B), Rf = 0.51 (system C)], were pooled, 
concentrated to a small volume and coevaporated with water (4 x 50 ml) to remove most of the 
triethylammonium bicarbonate and lyophilized from H2O. The residue was dissolved in water 
(20 ml) and the pH was adjusted to 2 by the addition of HCl (0.1 N) After 3 h at 20°C TLC analysis 
(system C) showed that the cleavage of the tetrahydro-2-pyranyl group was completed. 
The reaction solution was washed with diethylether (2 x 15 ml). The solution was neutralized 
with 25% aqueous amonia, concentrated to a small volume and applied to a column of Dowex 50 
Wx-8 cation-exchange resin (Na+-form, 1.5 x 5 cm). The column was eluted with water and all 
UV-positive eluate, were collected, concentrated to a small volume and lyophilized from D2O to 
give Z2 as white solid. Yield 0.28 g (81%), Rf = 0.42 (system C). 
Compound Z2, ! H NMR (D20): 5 = 8.20, s, 1H, H-8; 8.10, s, 1H, H-2; 5.60, t, J = 5.6 Hz, 1H, CH = C; 
4.20, d, 3jH-p = 8.3 Hz, 2H, CH2-O-P; 4.16 d, J = 6.4 Hz, 2H, CH2-N; 1.75, s, 3H, CH3; 13C NMR (D20): 
5 = 161.5, s, C6; 155.9, s, C2; 152.1, s, C4; 145.1, s, C8; 138.9, d, 3JC-p = 9.2 Hz, CH3-Ç = C; 122.3, s, ÇH = 
C; 118.6, s, C5; 69.9, br s, CH2-OP; 39.8, s, CH2-N, 14.4, s, CH3; 31P NMR (D20): Sp = 2.15 ppm. 
Synthesis of trans-zeatin methylphosphate Z% 
To solution A (see above) dry methanol (0.32 ml, 8 mmol) was added and this solution was left 
for 2 h at 20°C. Then solution was concentrated to a small volume and applied to a column of 
Sephadex LH 20. The column was eluted with (CH2C12/CH30H, 2:1, v/v). The fractions, 
containing product 815 [Rf = 0 (system B), Rf = 0.67 (system C)] were pooled and concentrated to 
an oil. After dissolving the oil in water (20 ml), the pH was adjusted to 2 with an aqueous 
hydrogen chloride solution (0.1 N). After 3 h at 20°C TLC analysis (system C) showed that the 
cleavage of the tetrahydro-2-pyranyl group was complete. The reaction solution was washed with 
diethylether (2 x 15 ml). The solution was neutralized with 25% aqueous ammonia, concentrated 
to a small volume and applied to a column of Dowex 50 Wx-8 cation-exchange resin (Na+-form. 
1.5 x 5 cm). 
The column was eluted with water and all UV-positive eluates, were collected, concentrated to 
small volume and lyophilized from D 20 to give Z3 as white solid. Yield 0.25 g (75%), Rf = 0.59 
(system C). 
Compound Z3, JH NMR (D20): 5 = 8.12, s, 1H, H-8; 8.06, s, 1H, H-2; 5.68, t, ]=5.5 Hz, 1H, CH = C; 
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4.30, d, 3jH.p = 7Hz, 2H, CH2-OP; 4.13, d, J = 5.8 Hz, 2H, CH2-N; 3.55, d, 3JH-P = 10.7 Hz, 3H, CH3-O-
P; 1.78, s, 3H, CH3; 13C NMR (D20): 5 = 155.3, s, C6; 154,2, s, Q ; 152,7, s, Q ; 142.9, s, C8; 137.8, d, 3JC-P 
= 5.5 Hz, CH3-Ç = C; 123.9, s, ÇH = C; 118.1, s, C5; 72.0, br s, CH2-OP; 54.6, br s, CH3O-P; 40.4, s, CH2-
N; 14.0, s, CH3; 31P NMR (D20): Sp = 2.10 ppm. 
Synthesis of trans-zeatin thiophosphate Z4 
Crude 5 (synthesized from 1 mmol of 3) was coevaporated with dioxane and dissolved in 
dioxane (10 ml). The solution was treated with N, N-diisopropylethylamine (0.35 mmol, 2 
mmol) and N-O-bis (trimethylsilyl) acetamide (0.5 ml, 2 mmol). After 15 min powdered sulfur 
(1.0 g, 4 mmol) was added. TLC analysis (system C) revealed that it requires 16 h to complete the 
conversion of phosphonate 5. Water was added and excess of sulfur was removed by filtration. 
The resulting solution was evaporated and dissolved in water and applied to a column of DEAE-
Sephadex A 25 (HC03-form), suspended in triethylammonium bicarbonate buffer (0.05 M). 
The column was eluted with a linear gradient of triethylammonium bicarbonate buffer 
(0.05 -> 0.7 M) for 18 h with a flow rate of 35 ml/h. Fractions of 10 ml were collected and all UV-
positive eluates, containing product 916, Rf = 0 (system B), Rf = 0.48 (system C), were pooled. They 
were concentrated to a small volumn, coevaporated with water (4 x 50 ml) to remove most of 
triethylammonium bicarbonate and lyophilized from H20. The residue was dissolved in water 
(20 ml) and the pH was adjusted to 2 by the addition of aqueous hydrogen chloride (0.1 N). After 
3 h at 20°C, TLC analysis (system C) showed that the cleavage of the tetrahydro-2-pyranylgroup 
was complete. 
The reaction solution was washed with diethylether (2 x 15 ml). The solution was neutralized 
with 25% aqueous ammonia, concentrated to a small volume and applied to a column of Dowex 
50 Wx-8 cation -exchange resin (Na+-form, 1.5 x 5 cm). 
The column was eluted with water and all UV-positive eluates were collected, concentrated to a 
small volume and lyophilized from D 20 to give Z4 as white solid. Yield 0.3 g (83%), Rf = 0.40 
(system C). 
Compound Z4, ! H NMR (D20): 5 8.20, s, 1H, H-8; 8.10, s, 1H, H-2; 5.62, t, J= 6Hz, 1H, CH=C; 4.20, d, 
3JH-P = 8Hz, 2H, CH2-0-P; 4.15, d, J = 6 Hz, 2H, CH2-N; 1.75, s, 3H, CH3; 13C NMR (D20): 8 162.9, s, 
C6; 154.7, s, C2; 152.5, s, C4; 147.1, s, C8; 137.9, d,3Jc-p=ll.l Hz, CH3-£=C; 122.7, s, ÇH=C; 117.4, s, C5; 
70.0, d, 2Jc-P = 11.1 Hz, CH2-OP; 39.4, s, CH2-N; 14.0, s, CH3; 31P-NMR(D20): 8p=40.00 ppm. 
Synthesis of frans-zeatin phosphonate Zg 
Na+-salt of 5 (0.33 g, 0.84 mmol) was dissolved in water 20 ml and the pH was adjusted to 2 with 
HCL (0.1 N). After 3 h at 20°C TLC analysis (system C) showed that the cleavage of the tetrahydro-
2-pyranyl group was complete. 
The reaction solution was washed with diethylether (2 x 15 ml). The solution was neutralized 
with aqueous ammonia (25%) and concentrated to a small volume, then applied to a column of 
Dowex 50 Wx-8 cation-exchange resin (Na+-form, 1.5 x 5 cm). The column was eluted with water 
and all UV-positive eluates were collected, concentrated to a small volume and lyophilized from 
D2O to give Z5 as white solid. Yield 0.25 g (82%), Rf = 0.7 (system C). 
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Compound Z5, ! H NMR (D20): 6 8.28, s, 1H, H-8; 8.19, s, 1H, H-2; 6.76, d, lJH-p = 636 Hz, 1H, P-H; 
5.70, t, J = 7.2 Hz, 1H, CH = C; 4.31, d, 3JH-p = 9 Hz, 2H, CH2-OP; 4.24, d, J = 6.0 Hz, 2H, CH2-N; 1.8, 
s, 3H, CH3; 13c NMR (D20): 5 152.2, s, C6; 149.0, s, C2; 148.2, s, Q ; 139.4, s, C8; 137.2, d, 3JC-P = 12.94, 
CH3-£ = C; 121.5, CH = C; 119.2, s, C5; 70.5, br s, CH2-OP; 40.4, CH2-N; 14.0, s, CH3; 31P NMR (D20): 
5p = 6.70 ppm, 0)H-P = 633 Hz). 
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CHAPTER V 
A CONVENIENT NEW SYNTHESIS OF THE ALLYLIC PYROPHOSPHATE OF TRANS-ZEATIN 
INTRODUCTION 
Zeatin, the highly active stimulant of cell division in plant tissue cultures, was first isolated from 
zeamays, and has the structure 6-(4-hydroxy-3-methyl-E-but-2-enylamino) purine la1"5; both E-
and Z- isomers have been synthesized 6~10 (see fig.V.l). 
In a quite recent paper11 the unique importance of a new zeatin metabolite i.e. l b has been 
established in plants. The chemical preparation of this metabolite has been reported12. 
The synthesis of the allylic pyrophosphate of frans-zeatin lc however, has not been published 
yet. We now wish to report on the synthesis of this allylic pyrophosphate lc (see fig. V.l). 
Difficulties encountered in the synthesis of allylic pyrophosphates and subsequent purification 
can be traced to the fact that the pyrophosphate residues are superb leaving groups, especially 
when they are protonated13. Up to now there are two procedures for the synthesis of allylic 
pyrophosphate. The first procedure was reported in 195914 and has not been altered significantly 
since then. This one-pot sequence involves treatment of a mixture of an allylic alcohol and 
inorganic pyrophosphate with trichloroacetonitrile to generate a complex mixture of organic and 
inorganic mono-, di-, and triphosphates. Yield of the desired products rarely exceeds 30% and 
further losses are usually encountered during purification. In addition, the procedure becomes 
difficult to manage if more than 50 mg of the products are desired15. The second procedure, 
which was described by Poulter et al.15 is based on activation of an allylic alcohol by conversion 
into an allylic halide. The activated intermediates are treated with the tris-(tetra-n-
butylammonium) hydrogen pyrophosphate to obtain the allylic pyrophosphate ester. Yields vary 
between 34-80%, depending on the structure of the allylic alcohol. In order to examine this 
possibility for the preparation of the allylic pyrophosphate of trans-zeatin attemps were made to 
halogenate the allylic hydroxy group in frans-zeatin la by using either phosphorus tribromide, or 
N-chlorosuccinimide15. Both attempts gave rise to the formation of a lot of coloured products. 
It occurred to us that the above-mentioned problems inherent in the synthesis of allylic pyro-
phosphate of frans-zeatin could be circumvented by using the methodology which was originally 
devised by Khorana et al16, for the preparation of nucleoside-5'-pyrophosphate and which is 
based on the reaction between nucleoside-5'-phosphoromorpholidates and bis-(tri-n-
butylammonium) phosphate. In this paper this approach will be described. 
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RESULTS AND DISCUSSION 
The strategy we have adopted in order to examine this possibility consisted of the following steps 
(see scheme 1): i. the synthesis of allylic phosphoromorpholidate of fraws-zeatin i.e. 4; ii. the 
conversion of 4 into fraws-zeatin pyrophosphate lc (see scheme V.l). 
The synthesis of allylic phosphoromorpholidate 4 was performed according to a slight 
modification of the procedure of Hâta et al.17. Thus, allylic phosphonate of fraws-zeatin 2 (being 
prepared by a procedure described before)12 in acetonitrile was treated with N-Obis-(trimethyl-
silyl) acetamide in the presence of N,N-diisopropylethylamine to give intermediate bis-(trime-
thylsilyl) phosphite 3. Attemps to isolate 3 were unsuccessful. Without further purification 3 was 
treated with 2,2'-dipyridyldisulfide and the reaction solution was then treated with an excess of 
dry morpholine to give the allylic phosphoromorpholidate of frans-zeation 4 as identified by *H 
NMR, 13C NMR and 31p NMR1». 
The conversion of 4 into the allylic pyrophosphate lc was succesfully effected by treatment of a 
solution of 4 in dimethylformamide with mono-(tri-n-butylammonium) phosphate for 18 h at 
45° C. After work-up and purification the allylic pyrophosphate lc was obtained in good yield 
(70%). The identity of frans-zeatin allylic pyrophosphate was ascertained by ^H NMR, 13C NMR 
and 31P NMR-spectroscopy (see experimental part). 
The ^H NMR and 13C NMR-data of this compound are almost identical with those of trans-
zeatin la !0,l9,2l vvith exception of the ïH-absorption of CH2-O, which in zeatin is found as singlet 
at 3.8 ppm., and in zeatin pyrophosphate lc as doublet at about 4.34 ppm., caused by the coupling 
of ^H with 31P(3JH-p). 
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In the 13C NMR-spectra, the difference between zeatin la and zeatin pyrophosphate lc is obvious 
in the absorption of CH3Ç=C. The 13C singlet of CH3Ç=C in la becomes a doublet in the zeatin 
pyrophosphate. The doublet is caused by the coupling of 13C with 31P(3Jc-p)- Proton decoupled 31P 
NMR-spectroscopy revealed the presence of two doublets, one doublet at -10.10 ppm., (J =20.2 Hz) 
and another doublet at -7.00ppmv (J= 20.2 Hz). The doublets are caused by the coupling of 31P 
with 31P. The 31P chemical shifts and to a lesser extent 31P-31P coupling constants are dependent 
on pH, counterion and concentration15. 
From these results it can be unequivocally concluded that above mentioned procedure is a fast 
and simple method for the preparation of allylic pyrophosphate of zeatin. The reaction 
proceeded smoothly and the pure compound lc was isolated in a satisfactory yield. 
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EXPERIMENTAL 
General procedures 
N,N-diisopropylethylamine, acetonitrile and toluene were dried by refluxing with CaH2 for 16 h 
and then distilled. Dimethylformamide was dried by stirring overnight at room temperature 
with CaH2 and then distilled under reduced pressure; morpholine was distilled from sodium. 
All liquids were stored under nitrogen. N,0-bis-(trimethylsilyl) acetamide and 2,2'-
dipyridyldisulfide were purchased form Janssen Chemica (Belgium). Mono-(tri-n-butyl-
ammonium) phosphate was prepared as described previously16. Triethylammonium bicarbonate 
buffer was prepared by passing a stream of CO2 gas through a cooled (ice-water bath) 2M solution 
of triethylamine in deionized water until the solution became neutral. Schleicher and Schuil DC 
Fertigfolien F 1500 LS 254 were used for TLC. The following solvent systems were used: 
System A (chloroform/methanol, 80:20,v/v) and System B (isopropyl alcohol/concentrated 
ammonium hydroxide/water, 7:1:2, v/v). Short-column chromatography was performed on 
silanized silicagel RP 18 (Merck) 70-230 mesh ASTM. The column was eluted with water 
applying a methanol gradient (0—>50%), unless otherwise mentioned. DEAE Sephadex A25 
purchased from Pharmacia (Uppsala, Sweden). Cation-exchange resin (Na+-form): a solution of 
NaOH (2M; 100 ml) was passed over a column packed with cation-exchange resin (Dowex 50 Wx-
8, 100-200 mesh; Fluka H+- form, 1.5 x 5 cm) followed by washing of the column with sterile 
water until pH=7. JH NMR-spectra were measured at 300 MHz using a Bruker CXP 300 
spectrometer. 13C NMR-spectra were measured at 75.460 MHz using a Bruker CXP 300 
spectrometer; Proton noise decoupling was used. 31P NMR-spectrometer, chemical shifts are in 
ppm. relative to 85% H3PO4 as external standard. 
Synthesis of frans-zeatin pyrophosphate lc 
First the Na+-salt of fraws-zeatin phosphonate 212(0.20 g, 0.5 mmol) was repeatedly coevaporated 
with acetonitrile (4x10 ml), the residue was diluted with acetonitrile (5 ml) and this mixture was 
treated with N,N-diisopropylethylamine (0.35 ml, 2 mmol) and N,0-bis-(trimethylsilyl) aceta-
mide (0.5 ml, 2 mmol) and reacted for 15 min at 20°C. Then the solution was treated with 2,2'-
dipyridyldisulfide (130 mg, 0.6 mmol). After 1 h at 20°C TLC analysis system B showed complete 
absence of 2. Then an excess of morpholine was added (1 ml). After 18 h at 20°C TLC (system B ) 
showed the formation of 418 (Rf=0.85). Water was added (1 ml) and the reaction solution was left 
for 10 min at 20°C. The reaction solution was concentrated to a small volume and coevaporated 
with toluene (4x10 ml). The latter product was dissolved in dimethylformamide (5 ml) and a 
solution of mono-(tri-n-butylammonium) phosphate16 in dimethylformamide (0.5M, 5 ml) was 
added. The reaction mixture was rendered anhydrous by repeated coevaporation with toluene 
(3x10 ml) and left at 45°C; after 18 h TLC (system B) showed the complete conversion of 4 into lc. 
The reaction mixture was treated with tri-n-butylamine until the pH had become 8 and 
concentrated to a small volume (1 ml) and applied to a column of DEAE Sephadex A25 (HCO3" 
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form) suspended in triethylammonium bicarbonate buffer (0.05 M). The column was eluted with 
the same buffer (linear gradient 0.05—>1.0 M) for 18 h with a flow rate of 35 ml/h. Fractions of 10 
ml were collected and the UV-positive eluates containing only lc , [Rf = 0.3, (system B)] were 
pooled. They were concentrated to a small volume, coevaporated with water (4x50 ml) and 
lyophilized from H2O. The residue was dissolved in water (1 ml) and applied to a column of 
Dowex 50 Wx-8 cation-exchange resin (Na+-form, 1.5x5 cm). The column was eluted with water 
and all UV-positive eluates were collected, concentrated to a small volume and lyophilized from 
D2O to give lc as white solid. Yield 155 mg (70% based on 2), Rf=0.3 (system B). Compound lc ! H 
NMR (D20): 5 8.17, s, 1H, H-8; 8.06, s, 1H, H-2; 5.72, t, J=7.2 Hz, 1H, CH=C; 4.34, d, 3JP-H=6.9 HZ, 2H, 
CH2-O-P; 4.12, d, J=6.4 Hz, 2H, CH2-N; 1.76, s, 3H,CH3; 13c NMR (D20) : 154.1, s, C6; 153.2, s, C2; 
150.9, s, C4; 141.5, s, C8; 137.3, d, 3Jc-P=5.5 Hz, CH3-Ç>C;122.8, s,CH=C;116.9, s, C5; 70.5, s, CH2-O-P; 
39.4, s, CH2-N; 14.0, s, CH3; 31P NMR (D20): ÔP=-10.10, d, J=20.2 Hz, P(1);5P=-7.00, d, J=20.2 Hz, P(2). 
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CHAPTER VI 
THE SYNTHESIS OF CYTOKININ PHOSPHATES 
INTRODUCTION 
The cytokinins, a group of naturally-occurring compounds which are involved in a variety of 
aspects of plant development, are established to be N6-substituted derivatives of adenine, which 
occur either as a free-base, ribonucleoside or ribonucleotide. One of the first naturally-occurring 
adenosine derivatives with plant cell division promoting activity was isolated from extracts of 
sweet corn kernels (zeamays)1 and was identified as 6-[4-hydroxy-3-methyl-E-but-2-enylamino]-9-
(ß-D-ribofuranosyl) purine la, usually named ribosyl zeatin. The second adenosine derivative 
being isolated from extracts of lactobacillus acidophilus, was N6-(A2-Isopentenyl)adenosine i.e. 6-
(3-methyl-2-butenylamino)-9-(ß-D-ribofuranosyl)purine 2a (see fig. VI.l). 
Many workers in this field suggested the presence of phosphates of cytokinin ribonucleosides; up 
to now only two of these derivatives have been isolated3'4. These compounds were assigned the 
structures of ribosyl zeatin 5'-phosphate lb and N6-(A2-Isopentenyl)-adenosine 5'-phosphate 2b; 
these assignments are based on UV spectral data, enzymatic characterisation as well as 
ndependent synthesis. A number of chemical procedures has been reported for the synthesis of 
these ribonucleotides l b 6 and 2b4A 
The best approach described for the phosphorylation of the alcoholic group involved the use of 
the powerful phosphorylating agent pyrophosphoryl chloride5'6. The method is simple but 
requires a difficult purification procedure and gives relatively low yields (=40%). 
Attempts were made to synthesize ribosyl zeatin phosphate lb , ribosyl zeatin diphosphate lc and 
ribosyl zeatin allylic phosphate Id by using either pyrophosphoryl chloride, or a mixture of 2-
:yanoethylphosphate and dicyclohexylcarbodiimide in pyridine. Both attempts failed7. 
We report in detail a new and improved synthesis of l b and 2b, using the phosphotriester 
ipproach, and the synthesis of lc and Id, using the phosphite triester approach (see scheme VI.l). 
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RESULTS AND DISCUSSION 
The strategy we have adopted for the synthesis of the ribonucleoside phosphates lb , l c , Id and 2b 
consisted of the following steps: i. The preparation of properly protected ribonucleoside 
derivatives 6, 8,9 and 10, (see scheme VI.1); ii effective phosphorylation of the free hydroxyl 
groups in these ribonucleoside derivatives (see scheme 2 and 3); iii complete removal of all 
protective groups. 
In our strategy dealing with the preparation of properly protected ribonucleoside derivatives we 
used the base-labile acetyl group for the protection of the allylic hydroxy function, the acid-labile 
methoxymethylidene group for the protection of the 2'-OH and the 3-OH function and the acid-
base-labile terf-butyldimethylsilyl (TBDMS) group for the protection of the 5'-OH function. The 
TBDMS group was selectively removed in the presence of the other protective groups 
(methoxymethylidene and acetyl groups) by fluoride ions. 
6-Chloro-9-ß-ribofuranosyl purine 3, which was prepared by a procedure described before8, was 
converted into 6-chloro-9-(2',3'-0-methoxymethylidene-ß-D-ribofuranosyl) purine 4 (yield 70%) 
by treatment with trimethyl orthoformate in the presence of the monohydrate of toluene-p-
sulphonic acid. The TBDMS group was introduced at the 5'-hydroxy function of 4 by treatment 
with terf-butyldimethylsilyl chloride in pyridine, which afforded 6-chloro-9-(2',3'-0-methoxy 
methylidene-5'-0-tert-butyldimethylsilyl-ß-D-ribofuranosyl) purine 5 (yield 80%). 6-[4-Hydroxy-3-
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methyl-E-but-2-enylamino]-9-(2',3'-0-methoxymethylidene-5'-0-ferf-butyldimethylsilyl-ß-D-
ribofuranosyl) purine 6 and 6-[hydroxy-3-methyl-E-but-2-enylamino]-9-(2',3'-0-methoxy-
methylidene-ß-D-ribofuranosyl) purine 9 were produced in yields of 77% and 80% respectively by 
coupling of 4-hydroxy-3-methyl-E-but-2-enylamine10 with 5 and 4 respectively in refluxing n-
butanol in the presence of triethylamine. Coupling of 4 with 3-methylbut-2-enylamine11 under 
the same conditions as described above gave 6-[3-methylbut-2-enylamino]-9-(2',3'-0-
methoxymethylidene-ß-D-ribofuranosyl) purine 10 (yield 79%). 
The allylic hydroxy function on 6 was acylated by treatment of 6 with acetic anhydride in pyridine 
in the presence of 4-dimethylaminopyridine (DAP)12 to afford the fully protected compound 7 
(yield 94%). Selective removal of the TBDMS group in 7 was performed by treatment with tetra-
n-butylammonium fluoride (TBAF)13 in dioxane to give 6-[4-acetoxy-3-methyl-E-but-2-
enylamino]-9-(2',3'-0-methoxymethylidene-ß-D-ribofuranosyl) purine 8 (yield 82%). 
The above described procedures for the synthesis of properly protected ribonucleosides 6, 8, 9 and 
10 proved to be relatively fast and gave these partially protected ribonucleosides in good yields. 
All these reaction steps of above described methodology could be performed on a relatively large 
scale. The next step in our strategy deals with the effective phosphorylation of the free hydroxy 
groups on the properly protected ribonucleosides 6, 8, 9 and 10. So far, the bifunctional 
phosphorylating reagent N-morpholino O,0-bis[(ó-trifluoromethyl)benzotriazolyl] phosphate 
(reagent D) (see scheme VI.2) was found to be suitable for the preparation of 5'-monophosphates 
of nucleosides14. When we treated a solution of the nucleosides 10 or 8 in pyridine (see scheme 
VI.2) with reagent D in the presence of N-methylimidazole we succesfully obtained the 
phosphate triesters 11 and 12 respectively. These fully protected intermediates were not isolated 
but were hydrolyzed immediately to remove all protective groups. Treatment of intermediate 11 
with pyridine/water removed the protective group 6-trifluoromethylbenzotriazolyl and 
subsequent treatment with acid at pH=2 removed the morpholino as well as the 
methoxymethylidene group providing 2b (yield 73% based on 10). In case of 12 after treatment 
with pyridine/water the acetyl protective group was removed by treatment with aqueous 
ammonia and the morpholino as well as the methoxymethylidene function by acid treatment at 
pH=2 to yield lb (yield 68% based on 8). By ^H NMR, 13C NMR and 3 1P NMR data (see 
experimental part) these structures l b and 2b were unequivocally established. The Rf and UV 
data were identical as described in the literature4-5'6.The introduction of the phosphate group at 
the allylic hydroxy group7-15, leading to the compounds lc and Id by using the bifunctional 
phosphorylating reagent D was found to be unsuitable16. A new and efficient method for the 
phosphorylation of an allylic hydroxy group via a phosphite intermediate has been found16- This 
method is based on the initial phosphitylation of the allylic hydroxy group with salicyl 
chlorophosphite, followed by oxidation of the allylic phosphonate monoester to the 
corresponding phosphate monoester. 
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Application jof this phosphite triester-approach was already demonstrated in the preparation of 
the phosphate monoester of N-(4-hydroxy-3-methyl-E-but-2-enyl) phthalimide16 and further in 
the preparation of the phosphate monoester of 6-(4-hydroxy-3-methyl-3-E-but-2-enylamino) 
purine1 ').In order to examine this potential route we treated 6 and 9 in dioxane with the 
monofunctional reagent 2-chloro-4H-l/3/2-benzodioxaphosphorin-4-one (reagent K)17 (see 
scheme VI.3) in the presence of N,N-diisopropylethylamine for 5 min. It gave the phosphite 
triesters 13 and 14 respectively, which were hydrolyzed into 15 and 16 respectively. By ^H NMR, 
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13C NMR and 31P NMR data (see experimental part) these structures were proven. 
The oxidation of 15 and 16 was performed according to a slight modification the procedure of 
Hâta et al1^. A solution of 15 and 16 in acetonitrile when treated with N,0-bis(trimethylsilyl) 
acetamide (reagent L) in the presence of N,N-diisopropylethylamine for 15 min. gave the 
intermediates bis (trimethylsilyl phosphite) 17 and 18 respectively. Without further purification 
17 and 18 were treated with 2/2'-dipyridyldisulfide (reagent M) for lh and the reaction mixtures 
thus obtained were subsequently treated with water affording 19 and 20 respectively. The identity 
of 19 and 20 was ascertained by 'H NMR and 31P NMR spectroscopy. 
Cleavage of the acid-labile group TBDMS and methoxymethylidene group was effected by acid 
treatment at pH=2 for 3h to give after workup Id and lc respectively (overall yield of Id 76% 
based on 6, yield lc 70% based on 9). The identity of these phosphate derivatives Id and lc was 
ascertained by *H NMR- 13C NMR and 31P NMR. 
The ^H NMR and 13C NMR data of the ribosyl zeatin derivatives l b , lc and Id are almost 
identical in comparison with those of ribosyl zeatin la19; however we mention some exceptions: 
i) The ^-absorptions of H5' and H5" appear in ribosyl zeatin la as two pairs of double doublets 
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at 3.75 - 3.88 ppm., due to the fact that H5' and H5" have slightly different chemical shifts and 
KH5' - H5'VJ(H5'-H4VJ(H5"-H4'). i n ib and lc, however, the absorption of Hs' and H5" takes the 
form of an undefined multiplet at about 4.10 ppm. No conclusion can be drawn whether 31P 
coupling occurs with H5' and H5". ii) The ^-absorption of C=C-CH2-0 which in ribosyl zeatin la 
is found as singlet at 3.96 ppm., appears in lc and Id as a doublet at about 4.20 ppm. The doublets 
are caused by the coupling of ]H with 31P (3JP-H)- iü) The 13C-signal of CH3C=C features in ribosyl 
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zeatin la as a singlet at about 138 ppmv but in lc and Id as a doublet. Similarly the 13C-signals of 
C4' appear in ribosyl zeatin la as a singlet at about 85 ppm., but becomes in lb and le a doublet. 
The doublets are caused by the coupling of 13C with 31P (3Jc-p)-
When we compared the JH NMR and 13C NMR data of N6-(A2-Isopentenyl)adenine 2a20 with 
the data of its phosphate 2b, the same observations were made as decribed above concerning the 
^-absorption of H5' and H5" and the 13C-absorption of C4'. 
Proton decoupled 31P NMR spectroscopy revealed the presence of the expected number of 
resonance absorptions, which further proved the structural identity and purity of the 
compounds. From these results it can be unequivocally concluded that the methods described 
above are simple and reliable procedures for the preparation of cytokinin phosphates. These 
compounds are produced in satisfactory yields without the formation of any side-products. 
EXPERIMENTAL 
General procedures. 
Acetonitrile, N,N-diisopropylethylamine, dioxane, N-methylimidazole, pyridine, triethylamine 
and trimethyl orthoformate were dried by refluxing with CaH2 for 16h and then distilled. 
Dioxane was redistilled from UAIH4 (5 g/1). All liquids were stored under nitrogen. n-Butanol 
(analyzed grade Baker) was used without further purification. N,0-bis(trimethylsilyl)acetamide 
and 2,2'-dipyridyldisulfide were purchased from Janssen Chimica (Belgium). 6-Chloro-9-ß-D-
ribofuranosyl purine8, 4-hydroxy-3-methyl-E-but-2-enylamine:0, 3-methyl-2-butenylamine11, 
tetra-n-butylammonium fluoride (TBAF)13, 2-chloro-4H-l,3,2-benzodioxaphoshorin-4-one17 and 
N-morpholino 0,0-bis[(6-trifluoromethyl)benzotriazolyl)] phosphate14 were prepared as 
described previously. 
Triethylammonium bicarbonate buffer was prepared by passing a stream of CO2 gas through a 
cooled (ice-water bath) 2M solution of triethylamine in deionized water until solution became 
neutral. Schleicher and Schuil DC Fertigfolien F 1500 LS 254 were used for TLC, unless otherwise 
mentioned. The following solvent systems were used. System A (chloroform/methanol, 96:4, 
v/v), system B (chloroform/methanol 92:8, v/v), system C (chloroform/methanol, 90:10, v/v), 
system D (chloroform/methanol, 85:15, v/v) , system E (isopropyl alcohol/concentrated 
ammonium hydroxide/water, 7:1:2, v/v) and system F (n-butanol/acetic acid/water, 12:3:5, v/v, 
Whatman No. 1 paper was used for TLC). Compound were visualized by UV-light or by spraying 
with the appropriate reagents. Thus compounds containing ribofuranosyl moieties were 
visualized by spraying with sulfuric acid/methanol (20:80, v/v). The phosphor containing 
compounds were visualized by spraying with Zinzadze's reagent. Short column chromatography 
was performed on silicagel 60 (230-400 mesh ASTM) suspended in chloroform. DEAE-Sephadex 
A 25 was purched from Pharmacia (Uppsala, Sweden). Cation-exchange resin (Na+-form): a 
solution of NaOH (2M; 100 ml) was passed over a column packed with cation-exchange resin 
(Dowex 50 Wx 8, 100-200 mesh; Fluka H+-form, 1.5x5 cm) followed by washing of the column 
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with sterile water until pH=7. Sterile water and glass were used during the whole deblocking and 
purification processes. 
JH NMR spectra were measured at 300 MHz using a Bruker CXP 300 spectrometer; 13C NMR 
spectra were measured at 75.460 MHz using a Bruker CXP 300 spectrometer; Proton noise i 
decoupling was used. 31P NMR spectra were measured at 121.470 MHz using a Bruker CXP 300 
spectrometer, chemical shifts are in ppm. relative to 85% H3PO4 as external standard. Mass 
spectral data were obtained from an AEI MS 902 spectrometer equipped with a VG ZAB console. 
Synthesis of 6-chloro-9-(2',3'-Q-methoxymethylidene-ß-D-ribofuranosyl) purine 4 
A mixture of 6-chloro-9-ß-D-ribofuranosyl purine 3 (13.48 g, 47 mmol), toluene-p-sulphonic acid, 
monohydrate (0.83 g, 4.28 mmol) and dry trimethyl orthoformate (58 ml) was stirred for 16h at 
20°C. TLC (system B) indicated complete disappearance of the starting material. The mixture was 
taken up in chloroform (250 ml) and washed with an aqueous solution of sodium bicarbonate 
(IM, 2x100 ml) and water (2x100 ml). The organic layer was dried on MgS04, concentrated to an 
oil, which was chromatographed on a column of silicagel. Elution with CHCI3/CH3OH 
(100:0-^96:4, v/v) gave after evaporation pure 4 as oil. Yield 10.83 g (70%), Rf=0.60 (system B). 
Compound 4, lH NMR (CDCI3): 5 8.72, s, 1H, H-8; 8.41, s, 1H, H-2; 6.34, d, J=4.3 Hz, 1H, Hi'; 5.94, s, 
1H, ÇU-OCH3; 5.28, m, 1H, H2'; 5.14, m, 1H, H3', 4.53, m, 1H, H4'; 3.82-3.74, m, 2H, H5' and H5"; 
3.30., s, 3H, OCH3; 13CNMR (CDCI3): 5 151.71,151.1, 150.4, 144.5 and 117.5, 5xs (purine); 119.14, s, 
ÇH-OCH3; 92.1, s, Ci'; 87.0, s, C4'; 84.2, s, C3'; 80.9, s, C2'; 62.4, s, C5'; 52.7, s, OCH3; HRMS, found 
m/z 328.0571 Ci2Hi3N40535Cl requires 328.0574. 
Synthesis of 6-chloro-9-(2',3'-0-methoxymethylidene-5'-0-fert-butyldimethylsilyl-ß-D-ribofura-
nosyl) purine 5 
To a solution of 4 (4.65 g, 14.25 mmol) in pyridine (20 ml) was added ferf-butyldimethylsilyl 
chloride (2.40 g, 16 mmol) and the reaction mixture was left for 16h at 20°C. TLC (system A) 
indicated complete conversion of the starting compound. After the addition of ice (20 g) the 
reaction mixture was concentrated to an oil which was dissolved in CHCI3 (200 ml) and washed 
with an aqueous solution of sodium bicarbonate (IM, 2x100 ml) and water (2x100 ml). The 
organic layer was dried on MgSC>4, concentrated to an oil which was chromatographed on a 
column of silicagel. Elution with CHCI3/CH3OH (100:0->98:2, v/v) gave after evaporation pure 5 
as oil. Yield 5.02 g (80%), Rf=0.621 (system A). 
Compound 5, ! H NMR (CDCI3): 5 8.73, s, 1H, H-8; 8.36, s, 1H, H-2; 6.37, d, J=3Hz, 1H, Hi'; 5.95, s, 
1H, ÇH-OCH3; 5.30 m, 1H, H2'; 5.01, m, 1H, H3'; 4.97, m, 1H, H4'; 3.85-3.74, m, 2H, H5' and H5"; 
3.30, s, 3H, OCH3; 0.80, s, 9H (TBDMS); 0.00, s, 6H (TBDMS); 13C NMR (CDCI3): 5 152.1,151.8,150.4, 
143.7 and 118.2, 5xs (purine); 119.3, s, ÇH-OCH3; 91.8, s, Q ' ; 87.7, s, C4'; 84.9, s, C3'; 81.4, s, C2'; 63.4, 
s, C5', 52.8, s, CH-OÇH3; 25.9,18.2 and -5.5, 3xs (TBDMS); FD-MS m/z: 442(M+) Ci8H27N405Si35Cl; 
HRMS (M-CH3)+, found m/z 427.1209 Ci7H24N405Si35Cl requires 427.1204. 
Synthesis of 6-r4-hydroxy-3-methyl-E-but-2-enylaminol-9-(2',3'-Q-methoxymethylidene-5'-0-terf-
butyldimethylsilyl-ß-D-ribofuranosyl) purine 6 
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A solution of 5 (4.50 g, 10.16 mmol), aminoalcohol (reagent A, 1.50 g, 14.85 mmol), triethylamine 
(3 ml) in n-butanol (150 ml) was boiled under reflux for 3h. TLC analysis (system A) indicated 
that the conversion of the starting material was complete. The reaction solution was 
concentrated under reduced pressure to an oil, which was chromatographed on a column of 
silicagel. Elution with CHCI3/CH3OH (100:0-^97:3, v/v) gave after evaporation pure 6 as an oil. 
Yield 4.00 g (77%), Rf=0.40 (system A). 
Compound 6, ^H NMR (CDCI3): 6 8.40, s, 1H, H-8; 7.93, s, 1H, H-2; 6.32, t, J=5.35 Hz, 1H, NH-CH7; 
6.25, d, J=2.8 Hz, Hi'; 6.12, s, 1H, ÇH-OCH3; 5.65, t, J=6.8 Hz, 1H, CH=C; 5.38, m, 1H, H2'; 5.26, m, 
1H, H3'; 4.52 m, 1H, H4'; 4.36, br s, 2H, CH2-N; 4.04, s, 2H, C=C-CH2-0; 3.76-3.70, m, 2H, H5' and 
H5"; 3.43, s, 3H, OCH3; 1.73, s, 3H, CH3; 0.93, s, 9H, (TBDMS); 0.00, s, 6H, (TBDMS); 13C NMR 
(CDCI3): 5 154.3,153.2,150.0,142.0 and 119.8, 5xs (purine); 138.8, s, CH3-£=C; 119.9, s, CH=C; 117.7, 
s, ÇH-OCH3; 91.2, s, Ci'; 87.3, s, C4', 84.4, s, C3'; 81.4, s, C2'; 66.3, s, C=C-CH2-Q; 63.0, s, C5'; 51.6, s, 
CH-OCH3; 38.2, s, CH2-N; 13.7, s, CH3; 25.6, 18.2 and -5.6, 3xs (TBDMS); HRMS, found m/z 
507.2505 C23H37N506Si requires 507.2513. 
Synthesis of 6-[4-hydroxy-3-methyl-E-but-2-enylaminol-9-(2',3'-Q-methoxymethylidene-ß-D-
ribofuranosyl) purine 9 
A solution of 4 (3.00 g, 9.13 mmol) aminoalcohol (reagent A, 1.00 g, 10 mmol), triethylamine (3 
ml) in n-butanol (150 ml) was boiled under reflux for 3h. TLC analysis (system B) indicated that 
the conversion of the starting material was complete. The reaction solution was concentrated 
under reduced pressure to an oil, which was chromatographed on a column of silicagel. Elution 
with CHCI3/CH3OH (100:0->95:5, v/v) gave after evaporation pure 9 as an oil. Yield 2.90 (80%), 
Rf=0.44 (system B). 
Compound 9, JH NMR (CDC13): 5 8.26,1H, s, H-8; 7.79, s, 1H, H-2; 6.44, t, J=4.97,1H, NH-CH2; 6.16, 
d, J=3.37 Hz, 1H, Hi', 5.93, s, 1H, ÇH-OCH3; 5.62, t, J=7.21 Hz, 1H, CH=C; 5.33, m, 1H, H2'; 5.16, m, 
1H, H3', 4.50, m, 1H, H4'; 4.20, br s, 2H, CH2-N; 4.01, s, 2H, C=C-CH2-0, 3.98-3.93, m, 2H, H5' and 
H5"; 3.66, s, 3H, CH-OÇH3; 1.72, s, 3H, CH3; 13C NMR (CDCI3): 6 154.7,152.8,147.2,139.1 and 119.4, 
5xs (purine); 139.0, s, CH3-£=C; 120.6, s, £H=C; H7.5, s, ÇH-OCH3; 92.7, s, Q ' ; 87.4, s, C4'; 85.9, s, 
C3', 81.1, s, C2'; 67.1, s, C=C-CH?-0; 62.8, s, C5'; 52.8, s, CH-OCHV: 38.2, s, N-CH2; 13.8, s, CH3; 
HRMS, found m/z 393.1649 requires 393.1648. 
Synthesis of 6-f4-acetoxy-3-methyl-E-but-2-enylaminol-9-(2',3'-Q-methoxymethylidene-5'-0-tert-
butyldimethylsilyl-ß-D-ribofuranosyl purine 7 
To a solution of 6 (2.00 g, 3.94 mmol) in pyridine (10 ml) was added acetic anhydride (3 ml) and 4-
dimethylaminopyridine (150 mg). The reaction solution was stirred for 40h. TLC analysis (system 
A) indicated that the conversion of the starting material was complete. After the addition of ice 
(50 g) the reaction mixture was taken up in CHCI3 (150 ml) and washed with an aqueous solution 
of sodium bicarbonate (IM, 2x50 ml) and water (2x50 ml). The organic layer was dried on MgS04, 
concentrated to an oil, coevaporated with toluene (2x100 ml), the oil residue was 
chromatographed on a column of silicagel. Elution with CHCI3/CH3OH (100:0—>98:2, v/v) gave 
after evaporation pure 7 as an oil. Yield 2.03 g (94%), Rf=0.70 (system A). 
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Compound 7, ^H NMR (CDCI3): 8 8.36, s, 1H, H-8; 7.92, s, 1H, H-2; 6.24, t, J=6.0 Hz, 1H, NH-CH?: 
6.11, d, J=2.6 Hz, 1H, Hi'; 6.10, s, 1H, ÇH.-OCH3; 5.65, t, J=6.8 Hz, 1H, CH=C; 5.36, m, 1H, H2', 5.10, 
m, 1H, H3'; 4.40, s, 2H, C=C-CH2-0; 4.34, m, 1H, H4'; 4.28, br s, 2H, CH2-N; 3.75-3.70, m, 2H, H5' 
and H5"; 3.32, s, 3H, CH-OÇH3; 2.05, s, 3H, CH3-C=0; 1.74, s, 3H, CH3; 0.88, s, 9H (TBDMS), 0.00, s, 
6H, TBDMS; " C NMR (CDCI3): 5 170.0, s, CH3-C=0; 154.6, 153,3, 150.4, 138.7 and 119.2, 5xs 
(purine); 134.2, s, CH3-Ç_=C; 121.0, s, CH=C; 118.0, s, CH-OCH3; 90.4, s, Ci'; 86.5, s, C4'; 83.8, s, C3', 
81.0, C2'; 68.8, s, C=C-CH2-0: 63.2, s, C5'; 51.7, s, CH-OÇH3; 38.3, s, CH2-N; 20.8, s, CHvC=0,14.1 s, 
ÇU3=C; 25.8, 18.2 and -5.5, 3xs (TBDMS); FD-MS m/z: 549 (M+) Q5H39N5O7S1; HRMS (M-
CH3C02)+, found m/z 490.2483 C23H36N505Si requires 490.2486. 
Synthesis of 6-f4-acetoxy-3-methyl-E-but-2-enylaminol-9-(2' ,3'-Q-methoxymethylidene-ß-D-
ribofuranosyl) purine 8 
A solution of tetra-n-butylammonium fluoride in dioxane (0.5M, 17 ml) was added to 7 (2.03 g, 
3.7 mmol), which was coevaporated with dioxane and dissolved in dioxane (10 ml). The reaction 
solution was left for 30 min. at 20°C. TLC analysis (system C) indicated complete removal of the 
silyl group, water was added (2 ml) and the reaction mixture was concentrated to an oil, which 
was dissolved in CHCI3 (200 ml) and washed with an aqueous solution of sodium bicarbonate 
(IM, 2x100 ml) and water (2x100 ml). The organic layer was dried on MgS04, concentrated to an 
oil, which was chromatographed on a column of silicagel. Elution with CHCI3/CH3OH 
(100:0->96:4, v/v) gave after evaporation pure 8 as an oil. Yield 1.30 g (82%), Rf=0.56 (system C). 
Compound 8, ^H NMR (CDCI3): 5 8.00, s, 1H, H-8; 7.83, s, 1H, H-2; 6.60, t, J=5.5 Hz, 1H, NH-CH?; 
6.03, d, J=3.4 Hz, Hi'; 6.43, t, J=6.9 Hz, CH=C; 5.10, m, 1H, H2'; 4.90, m, 1H, H3'; 4.27, s, 2H, C=C-
CH2-0; 4.00, br s, 2H, CH2-N; 3.66, m, 1H, H4'; 3.35-3.0, m, 2H, H5' and H5"; 1.85, s, 3H, CHyC=C; 
1.57, s, 3H, ÇU3-C=0; 13c NMR (CDCI3): 6 171.0, s, CH3-Ç=0; 154.5,152.6,141.0,139.1 and 119.3, 5xs 
(purine); 133.9, s, CH3-£=C; 117.5, s, ÇU-OCH3; 92.4, s, Ci'; 85.8, s, C4'; 83.3, s, C3'; 80.8, s, C2'; 72.1, s, 
C=C-CH?-0; 62.6, s, CHvC=Q; 13.2, s, CH3; HRMS, found m/z 435.1742 Ci9H25N507 requires 
435.1754. 
Synthesis of 6-r3-methyl-2-butenylamino1-9-(2',3'-Q-methoxymethylidene-ß-D-ribofuranosyl) 
purine 10 
A solution of 4 (2.00 g, 6.00 mmol), aminoalcohol (reagent B, 1.02 g, 12 mmol), triethylamine (1.8 
ml) in n-butanol (150 ml) was boiled under reflux for 3h. TLC analysis (system B) indicated that 
the conversion of starting material was complete. The reaction solution was concentrated under 
reduced pressure to an oil which was chromatographed on a column of silicagel. Elution with 
CHCI3/CH3OH (100:0^96:4, v/v) gave after evaporation pure 10 as an oil. Yield 1.80 g (79%), 
Rf=0.60 (system B). 
Compound 10, ^H NMR (CDCI3): 5 8.26, s, 1H, H-8; 7.75, s, 1H, H-2; 6.14, m, 2H, NH-CH2 and Hi'; 
5.91, s, 1H, ÇJH-OCH3; 5.29, t, J=6.88 Hz, 1H, CH=C; 5.19 m, 1H, H2'; 4.50, m, 1H, H3'; 4.14, br s, 2H, 
CH2-N; 3.90, m, 1H, H4'; 3.75-3.70, m, 2H, H5' and H5"; 3.41, s, 3H, CH-OCH3; 1.69, s, 3H, CH3-£=C; 
1.67, s, 3H, CH3-C=C; 13C NMR (CDCI3); 5 154.6, s, 152.6,147.1, 138.8 and 119.1, 5xs (purine); 136.2, 
s, (CH3)2-£=C; 120.6, CH=C; 119.9, CH-OCH3; 92.54, s, Q ' ; 87.3, s, C4'; 83.74, s, C3'; 81.05, s, C2'; 62.6, 
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s, C5'; 52.3, s, CH-OÇH3, 25.3 and 17.5, 2xs (CH^b-C^; HRMS, found m/z 377.1696 C17H23N5O5 
requires 377.1699. 
Synthesis of 6-f4-hydroxy-3-methyl-E-but-2-enylaminol-9-(5'-Q-phosphate-ß-D-ribofuranosyl) 
purine lb (ribosyl zeatin 5'-phosphate) 
A solution of phosphorylating agent N-morpholino O,0-bis[(6-trifluoromethyl)benzotriazolyl] 
phosphate in dioxane (reagent D, 0.2M, 4.5 ml, 0.90 mmol) was added to 6 (0.22 g, 0.5 mmol) 
which was coevaporated with pyridine (3x5 ml) and dissolved in pyridine (5 ml). N-
methylimidazole (0.07 ml, 0,93 mmol) was then added. After lh TLC analysis (system B) 
indicated complete conversion of the purine compound 8 into intermediate 12, Rf=0.77, water 
was then added to the reaction mixture (3 ml). After lh TLC (system B) showed the formation of 
a new product with zero mobility. The reaction mixture was evaporated and the residue was 
diluted with 25% aqueous ammonia (10 ml) to remove the acetyl group and the mixture was left 
for 20h at 20°C. The reaction mixture was concentrated to a small volume. The residue was 
diluted with water (15 ml) and the pH was adjusted to 2.0 by the addition of HCl (0.1N) to 
remove methoxymethylidene and morpholino groups. After 15h at 20°C the reaction mixture 
was extracted with diethyl ether (2x100 ml). Then the pH of the aqueous layer was adjusted to 8.0 
with aqueous ammonia 25%, concentrated to a small volume (1 ml) and was applied to a 
column of DEAE-Sephadex A25 (HCC>3~-form) suspended in triethylammonium bicarbonate 
buffer (0.05M). The column was eluted with a linear gradient of triethylammonium bicarbonate 
buffer (0.05—>0.7M) for 16h with a flow rate of 35 ml/h. Fractions of 10 ml were collected and all 
UV-positive eluates, containing purine product lb , [Rf=0 (system D), Rf=0.34 (system E)], were 
pooled, concentrated to a small volume and coevaporated with water (4x50 ml), and lyophilized 
from H2O. The residue was dissolved in water (2 ml) and applied to a column of Dowex 50 Wx-8 
cation-exchange resin (Na+-form, 1.5x5 cm). 
The column was eluted with water and all UV-positive eluates were collected, concentrated to a 
small volume and lyophilized from D2O to give lb as a white solid. Yield 160 mg (68% based on 
6), [Rf=0.34 (system E), Rf=0.20 (system F)]. Product identity was confirmed by UV and thin-layer 
chromatography, which was identical as described in the literature7, and further with 31P NMR, 
l ^ N M R a n d ' H N M R . 
Compound lb , lH NMR (D20): 8 8.39, s, 1H, H-8; 8.20, s, 1H, H-2; 6.00, d, J =5.5 Hz, Hi'; 5.59, t, J=6.6 
Hz, 1H, CH=C; 4.73, t, J=5.5 Hz, H2'; 4.48, dd, J(H3'-H4')=4.1 Hz, J(H3'-H2')=4.8 Hz, 1H; H3'; 4.38 , m, 
1H, H4'; 4.19, brd, J=4.8 Hz, 2H, CH2-N; 4.10, m, 2H, H5' and H5"; 4.00, s, 2H, C=C-CH2-0; 1.74, s, 
3H, CH3; 13C NMR (D20): 6 155.3,153.4,150.1,140.1 and 119.8, 5xs (purine); 139.7, s, CH3-£=C; 88.3, 
s, Q ' ; 85.7, d, 3Jc-P=3.7 Hz, C4'; 77.3, s, C3'; 73.0, s, C2'; 71.0, s, C=C-CHZ-Q; 68.0, s, C5'; 40.2, s, CH2-
N, 14.3, s, CH3; 31p NMR (D20): 5P=1.10 ppm. 
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Synthesis of 6-r3-methyl-2-but-enylamino1-9-(5'-Q-phosphate-ß-D-ribofuranosyl) purine 2b TN6-
(A2-Isopentenyl)adenosine 5'-phosphate1 
A solution of phosphorylating agent N-morpholino O,0-bis[(6-trifluoromethyl)benzotriazolyl 
phosphate (reagent D) in dioxane (0.2M, 4.77 ml), 0.95 mmol) was added to purine compound 10 
(0.20 g, 0.53 mmol), which was coevaporated with pyridine (2x10 ml) and dissolved in pyridine (5 
ml), N-methylimidazole (0.08 ml, 1 mmol) was then added. After lh TLC analysis (system B) 
indicated complete conversion of purine compound 10 into intermediate 11, Rf=0.82. Water was 
then added to the reaction mixture (3 ml). After lh TLC analysis (system B) showed the 
formation of new product with zeromobility. The reaction mixture was evaporated and the 
residue was diluted with water (15 ml) and the pH was adjusted to 2.0 by the addition of HCl 
(0.1N) to remove methoxymethylidene as well as the morpholino groups. After 15h at 20°C the 
reaction mixture was extracted with diethyl ether (2x100 ml). The pH of the aqueous layer was 
adjusted to pH=8.0 with aqueous ammonia 25%. The reaction solution was concentrated to a 
small volume (1 ml) and was applied to a column of DEAE-Sephadex A25 (HC03~-form) 
suspended in triethylammonium bicarbonate buffer (0.05M) to give after work up and 
purification as described in the synthesis of lb the sodium salt of 2b as a white solid. Yield 177 mg 
(73% based on 10), Rf=0.35 (system E), product identity was confirmed by UV and thin-layer 
chromatography which was identical as described in the literature4'5 and further with 31P NMR, 
13C NMR and ] H NMR. 
Compound 2b, ÏH NMR (D20): S 8.42, s, 1H, H-8; 8.19, s, 1H, H-2; 6.08, d, J=6 Hz, 1H, Hi'; 5.36, t, 
1=5.9 Hz, 1H, CH=C; 4.70, t, J=5.8 Hz, 1H, H2'; 4.45, dd, J(H3'-H4,)=3.9 Hz, J(H3'-H2')=4.9 Hz, 1H, 
H3'; 4.32, m, 1H, H4'; 4.00, br d, J=6.3 Hz, 2H, CH2-N; 4.08, m, 2H, H5' and H5"; 1.70, s, 3H, CH3; ^C 
NMR (D20): 5 154.3,152.9,148.1,139.2,118.8, 5xs (purine); 137.9, s, (CH3)2-C=C; 87.0, s, Q ' ; 84.2, d, 
3jc_p=8.2 Hz, C4'; 74.5, s, C3'; 70.6, s, C2'; 64.2, s, C5', 38.9, s, CH2-N; 24.8 and 17.3, 2xs, i£H3h-C=C; 
31P NMR (D20): 8P=1.3 ppm. 
Synthesis of 6-r4-Q-phosphate-3-methyl-E-but-2-enylaminol-9-ß-D-ribfuranosyl) purine Id 
(ribosyl zeatin allylic phosphate) 
To a solution of 6 (0.20 g, 0.40 mmol) and N,N-diisopropylethylamine (0.10 ml, 0.56 mmol) in 
dioxane was added 2-chloro-4H-l,3,2-benzodioxaphosphorin-4-one (reagent K, 114 mg, 0.56 
mmol). After reaction for 5 min. at 20°C, it was found by TLC analysis (system C) that complete 
conversion of starting compound into a product with zeromobility has taken place. Water was 
added (1 ml) and the solution was left for 10 min. at 20°C to give 15 [Rf=0 (system D), Rf=0.67 
(system E)]. The reaction solution was concentrated to a small volume and triturated with 
diethyl ether, the precipitated oil was coevaporated with acetonitrile (4x10 ml) and dissolved in 
acetonitrile (10 ml). The solution was treated with N,N-diisopropylethylamine (0.15 ml), 0.80 
mmol) and N,0-bis(trimethylsilyl) acetamide (0.2 ml, 0.8 mmol). After 15 min. the reaction 
solution was further treated with 2,2'-dipyridyldisulfide (160 mg, 0.48 mmol) after lh at 20°C TLC 
analysis (system E) indicated the complete conversion of 15. 
Then water was added (3 ml) and the reaction solution left for 2h at 20°C to give 19 with Rf=0.40 
(system E). The reaction solution was concentrated to an oil and dissolved in water (20 ml). The 
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pH of the resulting solution was adjusted to pH=2 by the addition of HCl (0.1N). After 3h at 20°C 
TLC analysis (system E) showed that the cleavage of (TBDMS) as well as methoxymethylidene 
was complete. The reaction solution was washed with diethyl ether (2x100 ml). The aqueous 
layer was neutralized to pH=8.0 with aqueous ammonia 25%, concentrated to an oil and applied 
to a column of DEAE-Sephadex A25 (HCC>3_-form) suspended in triethylammonium bicarbonate 
buffer (0.05M). The column was eluted with a linear gradient of triethylammonium buffer 
(0.05->0.70M) for 15h with a flow rate of 35 ml/h and fractions of 8 ml were collected. All UV-
; positive eluates containing Id , [Rf=0 (system D), Rf=0.30 (system E)] were pooled and 
concentrated to a small volume, coevaporated with water (4x50 ml) and lyophilized from H2O. 
The residue was dissolved in water (2 ml) and applied to a column of Dowex 50 Wx-8 cation-
exchange resin (Na+-form, 1.5x5 cm). The column was eluted with water and all UV-positive 
eluates were collected, concentrated to a small volume and lyophilized from D2O to give Id as a 
white solid. Yield 145 mg (76% based on 6), Rf=0.30 (system E). 
Compound Id, JH NMR (D20): 5 8.19, s, 1H, H-8; 8.12, s, 1H, H-2; 6.00, d, J=6.3 HZ, 1H, Hi'; 5.65, t, 
J=6.2 HZ, 1H, CH=C; 4.72, t, J=6.2 Hz, 1H, H2'; 4.38, dd, J(H3'-H2')=5.2 Hz, J(H3'-H4')=3.3 Hz, 1H, 
H3'; 4.24, m, 1H, H4'; 4.16, d, 3JH-P=5.4 Hz, 2H, C=C-CHZ-Q: 4.10, br s, 2H, CH2-N; 3.88-3.75, 2xdd, 
J(H5'-H5")=12.8 Hz, J(H5'5"-H4')=2.5 Hz and 3.4 Hz, 2H, H5' and H5"; 1.73, s, 3H, CH3; 13C NMR 
(D20): 5 154.7,153.1,148.2,140.3 and 119.9, 5xs (purine); 138.2, d, 3JC-P=7.4 Hz, CH3-(>C; 121.0, s, 
CH=C, 88.5, s, Ci'; 85.8, s, C4'; 74.0, s, C3'; 70.7, s, C2', 68.9, s, C=C-CH2-Q, 61.8, s, C5'; 38.8, s, CH2N; 
13.4, s, CH3; 3 1P NMR (D2O): 5p=2.12 ppm.; compounds 15 and 19 were identified after 
purification by using a column of DEAE-Sephadex A 25 (HC03~-form); the purified compounds 
were converted into sodium salts by passing it over Dowex 50 Wx-8 (Na+-form). 
Compound 15,T H-NMR (D20): 6=8.15, s, 1H, H-8; 8.10, s, 1H, H-2; 6.95, d, 1Jp-H=632 Hz, 1H, P-H; 
6.28, d, J=2.2 Hz, 1H, Hi'; 6.17, s, 1H, ÇH-OCH3; 5.60, t, J=6.5 Hz, 1H, CH=C; 5.40, m, 1H, H2'; 5.17, 
m, 1H, H3', 4.45, m, 1H, H4'; 4.35, d, 3JH-P=8 Hz, 2H, C=C-CHZ-Q: 4.17, br d, J=6.5 Hz, 2H, CH2-N, 
3.88-3.72, m, 2H, H5' and H5", 3.42, s, 3H, CH-OÇH3; 1.72, s, 3H, CH3; 0.80, s, 9H, TBDMS; 0.00, s, 
6H, TBDMS, 13C NMR (D20): 8 155.5,153.9,147.2,141.2 and 119.7, 5xs (purine); 137.1, d, 3Jc-P=5.4 
Hz; CH3 Q=C; 123.1, s, CH-OCH3; 120.1, s, CH=C; 91.4, s, Q ' ; 86.6, s, C4'; 83.0, s, C3'; 81.5, s, C2', 69.8, 
s, C=C-CH7-Q; 62,8, s, C5'; 51.7, s, CH-OCH3; 39.7, s, CH2-N; 26.4,18.8 and -5.0, 3xs (TBDMS); 14.4, s, 
CH3; 31p NMR (D20): 5P=6.77 ppm., 1JP-H=633 Hz. 
Compound 19, ^H NMR (D20): S 8.5, s, 1H, H-8; 8.2, s, 1H, H-2; 6.22, d, ]=4 Hz, 1H, Hi'; 6.15, s, 1H, 
ÇJi-OCH3; 5.56, t, J=6.4 Hz; 1H, CH=C; 5.23, m, 1H, H2'; 4.50, m, 1H, H3'; 4.28, m, 5H, CH2-N, H4' 
and C=C-CH2-0; 3.82-3.75, m, 2H, H5' and H5"; 3.75, s, 3H, CH-OÇH3; 1.74, s, 3H, CH3; 0.88, s, 9H, 
TBDMS; 0.00, s, 6H, TBDMS;, 31P NMR (D20): Sp=2.20 ppm. 
Synthesis of 6-f4-Q-phosphate-3-methyl-E-but-2-enylaminol-9-(5'-Q-phosphate-ß-D-
ribofuranosyl) purine lc (ribosyl zeatin diphosphate) 
Ribosyl zeatin diphosphate lc was synthesized in a similar procedure as described in the 
synthesis of ribosyl zeatin allylic phosphate Id, thus diphosphonate derivative 16 was obtained 
from ribofuranosyl derivative 9 (0.20 g, 0.5 mmol), l,3,2-benzodioxaphosphorin-4-one (reagent K, 
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0.28 g, 1.4 mmol) and N,N-diisopropylethylamine (0.26 ml, 1.4 mmol). The oxidation of 
diphosphonate derivative 16, Rf=0.56 (system E) to diphosphate derivative 20 was realized by 
using N,Obis(trimethylsilyl) acetamide (0.5 ml, 2 mmol), N,N-diisopropylethylamine (0.35 ml, 2 
mmol) and 2,2'-dipyridylsulfide (260 mg, 1.2 mmol). 
The diphosphate derivative 20, Rf=0.35 (system E) was acidified to pH=2 for 3h to give lc, Rf=0.28 
(system E), the latter was purified on a column of DEAE-Sephadex A25 (HC03~-form) eluted with 
a linear gradient of triethylammonium buffer (0.05—>1M) and was converted into its sodium salt, 
lc was obtained as white solid after lyophylization. Yield 210 mg, (70% based on 9), Rf=0.28 
(system E). 
Compound lc, lH NMR (D20): 5 8.40, s, 1H, H-8; 8.14, s, 1H, H-2; 6.05, d, J=5.8 Hz, 1H, Hi'; 5.65, t, 
J=6.6 Hz, 1H, CH=C; 4.71, t, J=5.5 Hz, 1H, H2'; 4.45, dd, J(H3'-H4')=3.7 Hz, J(H3'-H2')=5.2 Hz, 1H, 
H3'; 4.22, m, 1H, H4'; 4.22, d, 3JH-P=6.3 HZ, 2H, OC-CH^-O; 4.15, br d, J=5.8 Hz, 2H, CH2-N, 4.02, m, 
2H, H5' and H5"; 1.74, s, 3H, CH3; ™C NMR (D20): 5 154.7, 153.2, 148.5, 139.7 and 119.2, 5xs 
(purine); 137.1, d, 3JC-p=7.8 Hz, CH3-C=C; 122.1, s, CH=C; 87.42, s, Ci'; 84.5, d, 3Jc-P=5.6 Hz, Hi'; 
74.6, s, C3', 70.7, s, C2', 69.8, s, C=C-CH?-0, 64.28, s, C5'; 38.8, s, CH2-N; 13.4, s, CH3; 31P NMR (D20): 
5p=2.55 ppm. and 1.90 ppm.; compounds 16 and 20 were identified after purification by using a 
column of DEAE-Sephadex A 25 (HC03~-form); the purified compounds were converted into 
sodium salt by passing it over Dowex 50 Wx-8 (Na+-form). 
Compound 16, lH NMR (D20): 5 8.11, s, 1H, H-8; 8.00, s, 1H, H-2; 6.15, d, J=2.1 Hz, 1H, Hi'; 6.04, s, 
1H, CH-OCH3; 6.70, d, 1JH-P=635 HZ, 1H, P-H; 5.60, t, J=6.5 Hz, 1H, CH=C; 6.55, d, 1JH-P=639 HZ, 1H, 
P-H; 5.30, m, 1H, H2', 5.07, m, 1H, H3'; 4.56, m, 1H, H4'; 4.23, d, 3JH-P=8.6 HZ, 2H, C=C-CHZ-Q; 4.00, 
m, 4H, CH2-N, H5' and H5"; 3.43, s, 3H, CH-OCH3; 1.71, s, 3H, CH3; 13C NMR (D20): 5 154.3,153.0, 
147.8, 135.9 and 118.9, 5xs (purine); 139.5, d, 3Jc-P=8.3 Hz, CH3-£=C; 122.9, s, CH=C; 117.9, s, CH-
OCH3; 90.1, s, Ci'; 85.5, d, 3JC-p=7.4 Hz, C4'; 83.2, s, C3', 80.5, s, C2', 68.8, s, C=C-CHZ-Q; 63.4, s, C5'; 
52.7, s, CH-OŒ3; 38.6, s, CH2-N, 13.4, s, CH3; 31p NMR (D20): Sp=6.73 ppm. (1Jp.H=634.7 Hz) and 
5p=6.67 ppm., (1JP-H=631 Hz). 
Compound 20, 'H NMR (D20): 5 8.38, s, 1H, H-8; 8.15, s, 1H, H-2, 6.20, d, J=2.5 Hz, Hi', 6.06, s, 1H, 
ÇH-OCH3; 5.50, t, J=6.4 Hz, 1H, CH=C; 5.41, m, 1H, H2'; 5.14 m, 1H, H3', 4.30 m, 1H, H4'; 4.13, br d, 
J=5.4 Hz, s, 4H, CH2-N and C=C-CH7-Q: 3.91, m, 2H, H5'and H5'; 3.40, s, 3H, CH-OCH3; 1.71, d, 3H, 
CH3; 3^P NMR (D20): SP=4.30 ppm. and 4.22 ppm. 
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Hz, 1H, H3'; 4.31, m, 1H, H4'; 4.20, br d, J=3 Hz, 2H, CH2-N; 3.86-3.73, 2xdd, J(H5'-H5")=12.2 
Hz, J(H5'5"-H4')=2.5 Hz and 3.4 Hz, 2H, H5' and H5"; 1.71, s, 3H, CH3-C=C; 1.65, s, 3H, CH3-
C=C. 13C NMR (D20): 5 153.9,152.2,147.1,140.3,119.0, 5xs (purine); 137.6, s, CH3-£=C; 88.4, s, 
Ci', 85.5, s, C4', 73.9, s, C2', C3', 70.4, s, C2', 61.2, s, C5', 38.5,s, CH2-N, 24.5 and 16.9, 2xs, (CH^h-
C=C. 
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CHAPTER VII 
THE SYNTHESIS OF PHOSPHOR DERIVATIVES OF RIBOSYL ZEATIN 
INTRODUCTION 
Cytokinins are a class of hormones that were first isolated from plant tissues. They regulate cell 
division and growth in plants and participate in the differentiation process through their 
interaction with other plant hormones1. Certain cytokinins have also been shown to affect the 
behaviour of mammalian cells. For example, they have been reported to regulate the growth of 
mammalian cells2-3'4', to inhibit platelet aggregration5 and to have immunosuppressive 
activity6. Cytokinins have also been employed as potential anticancer agents in clinical trials7-8. 
Naturally occurring cytokinins are N6-substituted adenine derivatives and several highly active 
species have been isolated at the purine, ribonucleoside and ribonucleotide levels9*12. One of 
these adenine derivatives with plant cell division promoting activity was isolated13 from 
Zeamays and was identified as 6-(4-hydroxy-3-methyl-E-but-2-enylamino)-9-(ß-D-
ribofuranosyDpurihe i.e. la, usually named ribosyl zeatin. 
In an earlier work we reported on the synthesis of ribosyl zeatin phosphates14. Now we wish to 
describe the synthesis of some phosphor derivatives of ribosyl zeatin i.e. lb-lg (see fig. VII.1).. 
RESULTS AND DISCUSSION 
Recently we described a new and efficient method for the synthesis of the phosphate, methyl 
phosphate and thiophosphate monoester of the allylic hydroxy group in 6-(4-hydroxy-3-methyl-
E-but-2-enylamino)purine15. This method is based on the phosphitylation of the allylic hydroxy 
group with salicyl chlorophosphite yielding the allylic phosphonate monoester, and subsequent 
oxidation or sulphurization. 
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Fig. VII. 1 
We wanted to examine whether this methodology is also suitable for the synthesis of some 
phosphor derivatives of ribosyl zeatin i.e. lb-lg. 
According to a slight modification of the procedure of Hâta et al.16 ribosyl zeatin allylic 
phosphonate 2 and ribosyl zeatin bis(phosphonate) 3 (both compounds 2 and 3 being prepared by 
a procedure described before14) were treated with N,0-bis(trimethylsilyl)acetamide (reagent A) in 
the presence of N,N-diisopropylethylamine for 15 min. to give the intermediary 
bis(trimethylsilyl)phosphites 4 and 5, respectively (see scheme VII.1). Without any further 
purification both 4 and 5 were treated with 2,2'-dipyridyldisulfide (reagent D) and the reaction 
solution thus obtained was treated with dry methanol affording 6 and 7, respectively. The 
structures of 6 and 7 were ascertained by 'H-NMR and 31P-NMR spectroscopy. Treatment of 4 
and 5 with powdered sulfur for 15 h and subsequent treatment with water afforded the sulfur 
compounds 8 and 9, respectively. The structure of these compounds was ascertained by ïH-NMR 
and 31P-NMR spectroscopy. 
The cleavage of the acid-labile groups tert-butyldimethylsilyl (TBDMS) and methoxymethylidene 
n the derivatives 2, 3, 6, 7, 8 and 9 was effected by acid treatment at pH=2 for 3 h. The ribosyl 
zeatin allylic phosphonate l b , ribosyl zeatin bis(phosphonate) lc , ribosyl zeatin allylic 
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thiophosphate If, ribosyl zeatin bis(thiophosphate) lg, ribosyl zeatin allylic methyl phosphate l d 
and ribosyl zeatin bis(methyl phosphate) le were obtained in good yields. Over-all yields in the 
preparation of the compounds lb-lg fluctuated between 70% and 90% (calculated from 2 and 3). 
The structure of lb-lg was proven by ïH-NMR, 13C-NMR and 31P-NMR data. The !H-NMR and 
13C-NMR data of the ribosyl zeatin derivatives lb-lg bear a strong resemblance to those of ribosyl 
zeatin14. However, there are some exceptions: i. The ^H-absorption of H5' and H5" appears in 
ribosyl zeatin la as two pairs of double doublets at 3.75-3.88 ppm., due to the fact that H5' and H5" 
have slightly different chemical shifts and JCHs'-Hs") * JCHs'-H^) * J(H5"-H4'). In le, l e and lg 
the absorption of H5' and H5" appears as an undefined multiplet at about 4.10 ppm. No 
conclusion can be drawn whether 31P coupling occurs with H5' and H5". ii. The ^H-absorption of 
C=C-CH2-0 in ribosyl zeatin la is found as a singlet at 3.96 ppm., but in lb-lg this absorption 
appears as a doublet at about 4.20 ppm. The doublets are caused by the 3JH-P coupling, iii. The 13C-
resonance of CH3-C=C in ribosyl zeatin la is a singlet (at about 138 ppm.), but in lb- lg it is a 
doublet. Similarly, the 13C-signals of C4' appear in ribosyl zeatin la as a singlet at about 85 ppm., 
but in le, le and lg they appear as doublets, due to coupling of 13C with 31P(3Jc-p). Proton 
decoupled 31P-NMR spectroscopy revealed the presence of the expected number of resonance 
absorptions, which further proves the structural identity and purity of the compounds. 
In conclusion, the methodology described in this paper presents an elegant way for the synthesis 
of phosphate derivatives of ribosyl zeatin. The yields are satisfactory, the reaction proceeds 
smoothly under mild conditions. 
EXPERIMENTAL 
General procedures. 
N,N-diisopropylethylamine and acetonitrile were dried by refluxing with CaH2 for 16 h and then 
distiled. Methanol was dried by refluxing with magnesium methoxide and distiled before use. 
All liquids were stored under nitrogen. N,0-bis(trimethylsilyl)acetamide and 2,2'-dipyridyldi-
sulfide were purchased from Janssen Chimica (Belgium). Triethylammonium bicarbonate buffer 
was prepared by passing a stream of CO2 gas through a cooled (ice-water bath) 2 M solution of 
triethylamine in deionized water until the solution became neutral. Schleicher and Schuil DC 
Fertigfolien were used for TLC. The following solvent system was used: system A (isopropyl 
alcohol /concentrated ammomium hydroxide /water, 7:1:2, v/v). Short column chromatography 
was performed on Sephadex LH 20 suspended in CH2CI2/CH3OH (2:1, v/v), unless otherwise 
mentioned. DEAE-Sephadex A 25 was purchased from Pharmacia (Uppsala, Sweden). Cation-
exchange resin (Na+-form): a solution of NaOH (2 M; 100 ml) was passed over a column packed 
with cation-exchange resin (Dowex 50 Wx-8, 100-200 mesh; Fluka H+-form, 1.5x5 cm) followed by 
washing of the column with sterile water until pH=7. Sterile water and glass were used during 
the whole deblocking and purification processes. 'H-NMR spectra were measured at 300 MHz 
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using a Bruker CXP 300 spectrometer. 13C-NMR spectra were measured at 75.460 MHz using a 
Bruker CXP 300 spectrometer; proton noise decoupling was used. 31P-NMR spectra were 
measured at 121.470 MHz using a Bruker CXP 300 spectrometer, chemical shifts are in ppm 
relative to 85% H3PO4 as external standard. 
6-(4-0-Phosphonate-3-methyl-E-but-2-enylamino)-9-(2',3'-0-methoxymethylidene-5'-0-tert-butyl-
dimethylsilyl-ß-D-ribofuranosyl) purine 2 and 6-(4-0-phosphonate-3-methyl-E-but-2-enylamino)-
9-(2',3'-0-methoxymethylidene-5'-0-phosphonate-ß-D-ribofuranosyl)purine 3 were prepared as 
described previously14. 
Synthesis of 6-(4-0-methylphosphate-3-methyl-E-but-2-enylamino)-9-(ß-D-ribofuranosyl)purine 
ld (ribosyl zeatin allylic methylphosphate) 
The Na+-salt of 2 (0.25 g, 0.42 mmol) was repeatedly coevaporated with acetonitrile (4x10 ml). The 
residue was diluted with acetonitrile (5 ml) and this mixture was treated with N,N-
diisopropylethylamine (0.15 ml, 0.84 mmol) and N,0-bis(trimethylsilyl)acetamide (0.21 ml, 0.84 
mmol). After 15 min. the solution was reacted with 2,2'-dipyridyldisulfide (108 mg, 0.5 mmol) for 
1 h at 20°C. TLC analysis (system A) indicated the complete absence of 2. After addition of an 
excess of methanol (3 ml) the solution was left for 15 h at 20°C to give 6, Rf= 0.52 (system A). The 
reaction solution was concentrated to an oil and dissolved in water (20 ml). The pH of the 
resulting solution was adjusted to 2 by the addition of HCl (0.1 N). After 3 h at 20°C, TLC analysis 
(system A) showed that the cleavage of TBDMS as well as methoxymethylidene was complete. 
The reaction solution was washed with diethylether (2x100 ml). The aqueous layer was 
neutralized to pH=8.0 with aqueous ammonia (25%), concentrated to an oil and applied to a 
column of DEAE-Sephadex A 25 (HC03--form) suspended in triethylammonium bicarbonate 
buffer (0.05 M). The column was eluted with a linear gradient of triethylammonium buffer 
(0.05->0.50 M) for 15 h with a flow rate of 35 ml/h and fractions of 10 ml were collected. The UV-
positive eluates containing Id, Rf=0.37 (system A) were pooled and concentrated to a small 
volume, coevaporated with water (4x50 ml) and lyophilized from H2O. The residue was 
dissolved in water (1 ml) and applied to a column of Dowex 50 Wx-8 cation-exchange resin (Na+-
form, 1.5x5 cm). The column was eluted with water and all UV-positive eluates were collected, 
concentrated to a small volume and lyophilized from D2O to give Id as a white solid. Yield 144 
mg (74% based on 2). 
Compound Id; ^H-NMR (D20): 5 8.20, s, 1H, H-8; 8.10, s, 1H, H-2; 6.01, d, J=6.0 Hz, 1H, Hi'; 5.62, t, 
J=6.2 Hz, 1H, CH=C; dd, J(H3'-H2')=3.4 Hz, J(H3'-H4')=5.4 Hz, 1H, H3'; 2.28, m, 1H, H4'; 4.19, d, 3JH-
P=6.5 Hz, 2H, C=C-CH2-0; 3.90, brs, 2H, CH2-N; 3.86-3.50, 2xdd, J(H5'-H5")=12.8 Hz, KHs's"-
H4')=2.6 Hz and 3.4 Hz, 2H, H5' and H5"; 3.46, d, 3JH-p=10.8 Hz, 3H, P-OCH3; 1.70, s, 3H, CH3; 13C-
NMR (D20): 5 154.6,152.8,150.0,148.1 and 119.6, 5xs (purine); 136.2, d, 3Jc-P=6.3, CH3-£=C; 122.1, s, 
CH=C; 88.5, s, Ci'; 85.8, s, C4'; 74.1, s, C3'; 70.8, s, C2'; 70.7, s, C=C-CHZ-Q; 61.9, s, C5'; 53.7, s, P-OCH3; 
39.2, s, CH2-N; 14.0, s, CH3; 3lP-NMR (D20): 5P=2.17 ppm. 
Compound 6 was identified after purification by using a column of DEAE-Sephadex A25 (HC03"); 
the purified compound was converted into the sodium salt by passing it over Dowex 50 Wx-8 
(Na+-form). 
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Compound 6: ^ - N M R (D20): 5 8.05, s, 1H, H-8; 8.00, s, 1H, H-2; 6.10, d, J=4.1 Hz, 1H, Hi'; 6.00, s, 
1H, ÇH-OCH3; 5.58, t, J=6.2 Hz, 1H, CH=C; 5.5, m, 1H, H2'; 4.80, m, 1H, H3'; 4.60, m, 1H, H4'; 4.10, d, 
3JH-P=7.8 HZ, 2H, C=C-CH2-0; 4.00, m, 2H, CH2-N; 3.60, m, 2H, H5' and H5"; 3.50, d, 3JH-P=10.7 HZ, 
3H, P-OCH3; 3.15, s, 3H, CH-OÇH3; 1.70, s, 3H, CH3; 0.88, s, 9H, (TBDMS); 0.00, s, 6H, (TBDMS); 31P-
NMR (D20): 6p=2.19 ppm. 
Synthesis of 6-(4-Q-methylphoshate-3-methyl-E-but-2-enylamino)-9-(5'-Q-methylphosphate-ß-D-
ribofuranosyl) purine le Fribosyl zeatin bis(methylphosphate)l 
Since compound le was synthesized according to a similar procedure as described before in the 
synthesis of Id , we refrain from an extensive description and give here only some notes. The 
conversion of the Na+-salt of bis(phosphonate) derivative 3 (0.25 g, 0.44 mmol) into the 
bis(methylphosphate) derivative 7 was realized by using N,0-bis(trimethylsilyl)acetamide (0.44 
ml, 1.76 mmol), N,N-diisopropylethylamine (0.31 ml, 1.76 mmol), 2,2'-dipyridyldisulfide (228 
mg, 1.1 mmol) and methanol (4 ml). The bis(methylphosphate) 7, Rf=0.37 (system A) was 
acidified to pH=2. After 3 h le was obtained, Rf=0.31 (system A) which was purified on a column 
of DEAE-Sephadex A 25 (HCC>3"-form). The column was eluted with a linear gradient of 
triethylammonium buffer (0.05—»0.5 M) and was converted into its sodium salt. Compound l e 
was obtained as a white solid. Yield=192 mg (75% based on 3). 
Compound le; !H-NMR (D20): 5 8.36, s, 1H, H-8; 8.14, s, 1H, H; 6.02, d, J=5.6 Hz, 1H, Hi'; 5.62, t, 
J=6.5 Hz, 1H, CH=C; 4.30, t, J=5.9 Hz, 1H, H2'; 4.28, m, 1H, H3; 4.26, m, 1H H4'; 4.23, d, 3JH-P=6.6 Hz, 
2H, C=C-CHZ-Q; 4.21, brd, J=6.5, 2H, CH2-N; 4.12, m, 2H, H5' and H5"; 3.56, d, 3JH-P=12.6 Hz, 3H, P-
OCH3; 3.52, d, 3JH-P=12.6 HZ, 3H, P-OCH3; 1.70, s, 3H; 13C-NMR (D20): 8 151.8, 153.4,148.4,139.5, 
119.4, 5xs (purine), 136.2, d, 3JC-p=5.60 Hz, CH3-£=C; 123.1, s, CH=C, 87.6, s, Ci', 83.9, d, 3Jc-P=7.4 
Hz, C4'; 74.3, s, C3', 70.8, s, C2', 70.5, s, C=C-CH2-Q: 65.1, s, C5', 53.2, s, 2x(P-OCH3); 38.7, s, CH2-N; 
14.0, s, CH3; 31P-NMR (D20): 5P=1.90 ppm and 2.05 ppm, 
Compound 7 was identified after purification by using a column of DEAE-Sephadex A 25 
(HCO3"); the purified compound was converted into sodium salt by passing it over Dowex 50 
Wx-8 (Na+-form). 
Compound 7; ^H-NMR (D20): 5 8.22, s, 1H, H-8; 8.15, s, 1H, H-2; 6.30, d, J=2.6 Hz, 1H, Hi', 6.10, s, 
1H, ÇH-OCH3; 5.28, t, J=5.7 Hz, 1H, ÇH=C; 4.79, m, 1H, H2'; 4.74, m, 1H, H3'; 4.70, m, 1H, H4'; 4.26, 
d, J=7.0 Hz, 2H, C=C-CHZ-Q: 4.00, brd, J=4.2 Hz, 2H, CH2-N; 3.90, m, 2H, H5' and H5"; 3.40, d, 3JH-
P=10.0 Hz, 3H, P-OCH3; 3.36, d, 3JH-P=10.0 Hz, 3H, P-OCH3; 3.30, s, 3H, CH-OÇH3; 1.76, s, 3H, CH3; 
31P-NMR (D20): 8P=3.80 ppm and 4.21 ppm. 
Synthesis of 6-(4-0-thiophosphate-3-methyl-E-but-2-enylamino)-9-(ß-D-ribofuranosyl) purine If 
(ribosyl zeatin allylic thiophosphate) 
The Na+-salt of 2 (0.25 g, 0.42 mmol) was repeatedly coevaporated with acetonitrile (4x10 ml). The 
residue was diluted with acetonitrile (5 ml) and this mixture was treated with N,N-
diisopropylethylamine (0.15 ml, 0.84 mmol) and N,0-bis(trimethylsilyl)acetamide (0.21 ml, 0.84 
mmol). After 15 min. the solution was treated with powdered sulfur (1 g) for 16 hrs. TLC analysis 
(system A) revealed that 16 h is required to complete the conversion of phosphonate 2 into 
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thiophosphate 8, Rf=0.38 (system A). After this time water (1 ml) was added and the excess of 
sulfur was removed by filtration. The resulting solution was concentrated to a small volume and 
triturated with diethyl ether. The oil formed was dissolved in water (20 ml), the pH of this 
solution was adjusted to 2 by the addition of HCl (0.1 N). After 3 h at 20°C TLC analysis (system 
A) showed the complete cleavage of the TBDMS as well as the methoxymethylidene group. The 
reaction solution was washed with diethyl ether (2x100 ml), the aqueous layer was neutralized to 
pH=8.0 with aqueous ammonia (25%), concentrated to an oil and applied to a column of 
Sephadex LH 20. The column was eluted with CH2CI2/CH3OH (2:1, v/v). The fractions 
containing purine product If, Rf=0.28 (system A) were pooled, concentrated to an oil and applied 
to a column of Dowex 50 WX-8 cation-exchange resin (Na+-form 1.5x5 cm). The column was 
eluted with water and all UV-positive eluates were collected, concentrated to a small volume 
and lyophilized from D2O to give If as a white solid. Yield 167 mg (80% based on 2). 
Compound If; ^H-NMR (D20): 5 8.12, s, 1H, H-8, 8.00, s, 1H, H-2; 6.02, d, J=6.21 Hz, 1H, Hi'; 5.67, 
t=6.5 Hz, 1H, C_H=C; 4.60, brs, 1H, H2'; 4.14, dd, J(H3'-H2')=4.3 Hz, J(H3'-H4')=3.4, 1H, H3'; 4.27, m, 
1H, H4'; 4.17, d, 3JH-P=5.2 HZ, 2H, C=C-CH2-0; 4.25 brs, 2H, CH2-N; 3.75-3.90, 2xdd, J(H5'-H5")=12.8 
Hz, J(H5,5"-H4')=2.2 Hz and 3.4 Hz, 2H, H5' and H5"; 1.72, s, 3H, CH3; 13C-NMR (D20): 5 156.9, 
153.1,148.0, 140.0,119.5, 5xs (purine); 138.2, d, 3JC_P=7.4 Hz, CH3-£=C; 121.5, s, CH=C; 89.1, s, Q ' ; 
86.2, s, C4'; 74.6, s, C3'; 71.2, s, C2'; 67.9, s, C=C-CH?-Q; 62.6, s, C5'; 39.4, s, CH2-N; 14.0, s, CH3; 3lp-
NMR (D20): 5p=46.00 ppm; 
Compound 8 was identified after purification by using a column of Sephadex LH 20 suspended in 
CH2Cl2/CH3OH (2:1, v/v); the purified compound was converted into sodium salt by passing it 
over Dowex 50 Wx-8 (Na+-form). 
Compound 8; aH-NMR (D20): 5 8.25, s, 1H, H-8; 8.15, s, 1H, H-2, 6.20, d, J=3 Hz, 1H, Hi'; 6.05, s, 1H, 
CH-OCH3; 5.60, t, J=6.5 Hz, 1H, CH=C; 4.80, m, 1H, H2'; 4.72, m, 1H, H3'; 4.20, m, 5H, CH2-N, H4' 
and C=C-CH2-0; 3.80, m, 2H, H5' and H5"; 3.32, s, 3H, CH-OÇH3; 1.74, s, 3H, CH3; 0.85, s, 9H, 
(TBDMS); 0.00, s, 6H, (TBDMS); 31p-NMR (D20): 8P=43.01 ppm. 
Synthesis of 6-(4-0-thiophosphate-3-methyl-E-but-2-enylamino)-9-(5'-0-thiophosphate-ß-D-ribo-
furanosyl) purine lg fribosyl zeatin bis(thiophosphate)l 
Compound l g was synthesized according to the same procedure as described above in the 
synthesis of ribosyl zeatin allylic thiophosphate If; therefore only some notes are given. The 
sulfurization of the Na+-salt of bis(phosphonate) derivative 3 (0.25 g, 0.44 mmol) was performed 
by using N,N-diisopropylethylamine (0.31 ml, 1.76 mmol), N,0-bis(trimethylsilyl)acetamide (0.31 
ml, 1.76 mmol) and powdered sulfur (lg). The bis(thiophosphate) 9, R=0.33 (system A) was 
acidified to pH=2. After 3 h lg was obtained, Rf=0.25 (system A), which was purified by using a 
column of Sephadex LH 20 eluting with CH2Cl2/CH3OH (2:1, v/v). The purified compound was 
converted into its sodium salt, lg was obtained as white solid. Yield 227 mg (82% based on 3). 
Compound lg: ^H-NMR (D20): 5 8.52, s, 1H, H-8; 8.13, s, 1H, H-2; 6.00, d, J=5.1 Hz, 1H, Hi'; 5.60, t, 
J=6.2 Hz, 1H, CH=C; 4.54, dd, J(H3'-H4')= 5.3 Hz, J(H3'-H2')=3.4 Hz, 1H, H3'; 4.40, m, 1H, H4'; 4.30, 
d, 3JH-P=6.5 HZ, 2H, C=C-CH2-0; 4.10, m, 4H, CH2-N, H5' and H5"; 1.77, s, 3H, CH3; «C-NMR 
(D20): Ô 155.3,153.8,149.1,140.5 and 119.8, 5xs (purine); 137.8, d, J=7.3 Hz, CH3-C=C; 122.4, s, CH=C; 
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88.1, s, Ci'; 85.2, d, J=9.3 Hz; C4'; 75.4, s, C3'; 71.6, s, C=C-CH?-0: 70.4, s, C2'; 64.9, s, C5'; 39.5, s, CH2-
N; 14.0, s, CH3; 31p-NMR (D20): 5P=49.52 ppm and 48.40 ppm; 
Compound 9 was identified after purification by using a column of Sephadex LH 20 suspended in 
CH2CI2/CH3OH (2:1, v/v); the purified compound was converted into the sodium salt by passing 
it over Dowex 50 Wx-8 (Na+-form). 
Compound 9_; JH-NMR (D20): 5 8.44, s, 1H, H-8; 8.13, s, 1H, H-2; 6.30, d, J=3.4 Hz, 1H, Hi'; 6.20, s, 
1H, ÇH-OCH3; 5.61, t, J=5.6 Hz, 1H, CH=C; 5.43, m, 1H, H2'; 3.39, m, 1H, H3'; 4.67, m, 1H, H4'; 4.21, 
d, J=6.4 Hz, 2H, C=C-CH2-0; 4.15, brd, 2H, CH2-N; 4.07-3.98, m, 2H, H5' and H5"; 3.35, s, 3H, CH-
OÇH3; 1.75, s, 3H, CH3; 31p-NMR (D20): 8P=59.40 ppm. 
Synthesis of 6-(4-Q-phosphonate-3-methyl-E-but-2-enylamino)-9-(ß-D-ribofuranosyl) purine l b 
ribosyl zeatin allylic phosphonate) and of 6-(4-Q-phosphonate-3-methyl-E-but-2-enylamino)-9-
(5'-0-phosphonate-ß-D-ribofuranosyl) purine lc [ribosyl zeatin bis(phosphonate)1 
The Na+-salt of 2 (0.25 g, 0.42 mmol) and 3 (0.25 g, 0.44 mmol) respectively were dissolved in 
water (20 ml), the pH was adjusted to 2 with HCl (0.1 N) and this solution was kept for 3 h at 
20°C. TLC analysis (system A) showed that the cleavage of the TBDMS as well as 
methoxymethylidene group was then complete. The solution was washed with diethyl ether 
(2x100 ml), neutralized with aqueous ammonia (25%), concentrated to a small volume and then 
applied to a column of Dowex 50 Wx-8 cation-exchange resin (Na+-form, 1.5x5 cm). The column 
was eluted with water and all UV-positive eluates were collected, concentrated to a small 
volume and lyophilized from D20. The amount of l b obtained was 166 mg (90% based on 2) and 
the yield of lc was 200 mg (86% based on 3) respectively. 
Compound l c 1H-NMR(D20): 5 8.20, s, 1H, H-8; 8.08, s, 1H, H-2 6.68, d, 1JH-p=639.2, 1H, P-H; 6.66, 
d, 1JH-P=639.2 Hz, 1H, P-H; 6.00, d, J=5.4 Hz, 1H, Hi'; 5.60, t, J=6.8 H2,1H, CH=C; 4.66, t, J = 5.4,1H, 
H2'; 4.39, dd, J(H3'-H4') = 4.4 Hz, J(H3'-H2') = 5.0 Hz, 1H, H3'; 4.29, m, 1H, H4'; 4.23, d, 3jH-p = 8.8 
Hz, 2H, C=C-CH2-0; 4.07, m, 4H, CH2-N, H5' and H5"; 1.71, s, 3H, CH3; ^C-NMR (D20): 5 155.7, 
154.1,150.3,141.0,119.7, 5xs (purine); 136.8, d, 3Jc-p = 7.4 Hz, CH3-£=C; 123.3, s, CH=C; 88.1, s, C : '; 
84.7, d, 3Jc-p = 5.4 Hz, C4'; 77.7, s, C3'; 71.4, s, C2'; 69.8, s, C=C-CH?-Q: 64.0, s, C5'; 39.2, s, CH2-N; 14.0, 
s, CH3; 31p-NMR (D20): 6P=7.03 ppm, 1JH-P=634.8 Hz and 5P=6.65 ppm, lJH-p=632.3 Hz. 
Compound lb ; IH-NMR(D20): Ô 8.40, s, 1H, H-8; 7.73, s, 1H, H-2; 6.74, d, 1JH-p=636.7 Hz, 1H, P-H; 
6.05, d, J=6.3 Hz, 1H, Hi'; 5.60, t, J=6.5 Hz, 1H, CH=C; 4.52, dd, J=5.4 Hz and 3.4 Hz; 1H, H3'; 4.30, m, 
1H, H4'; 4.28, d, J=5.2 Hz, 2H, C=C-CH2-0; 4.25, brd, 2H, CH2-N; 3.90-3.75, 2xdd, J(H5'5")=12.8 Hz, 
J(H5'5'-H4')=2.2 Hz and 3.4 Hz, 2H, H5' and H5"; 1.72, s, 3H, CH3; "C-NMR (D20): 5 155.5, 153.7, 
148.6,140.2,119.6, 5xs (purine); 135.9, d, 3Jc-P=6 0 Hz, CH3-C=C; 122.9, s, CH=C; 88.5, s, Q ' ; 86.0, s, 
C4'; 73.9, s, C3'; 70.9, s, C2'; 69.0, s, C=C-CHz-0; 61.7, s, C5'; 38.7, s, CH2-N; 14.4, s, CH3; 31p-NMR 
(D20): 5p=6.51 ppm, 1]H-p=634.7 Hz. 
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CHAPTER VIII 
THE SYNTHESIS OF L (-) AND D (+) LUPINIC ACID 
INTRODUCTION 
L-amino acids, containing a heterocyclic ring on the ß-position of alanine, occur widely in 
nature and are produced in plants. In these non-protein L-amino acids six-membered 
heterocyclic rings (trigonelline, mimosine, willardine, and isowillardine), five-membered rings 
(quisqualic acid, ß-(pyrazol-l-yl)alanine, ß-(3-isoxazolin-5-on-2-yl)alanine, ß-(5-methylisoxa-
zolin-3-on-2-yl)alanine, ß-(3-amino-l,2,4-triazol-l-yl)alanine, ß-(2-furoyl)alanine, as well as 
bicyclic heterocycles (lupinic acid, ß-(6-benzoylaminopurin-9-yl)alanine, histidinoalanine are 
identified as ß-heterocyclic moieties. There is continuing interest in the synthesis of these 
naturally-occuring heterocyclic ß-substituted alanines1. Plant extracts have been isolated, which 
contain enzyme systems (ß-substituted alanine syntheses), which catalyze the syntheses of ß-
substituted heterocyclic alanines from O-acetyl L-serine and the appropriate heterocycle. It was 
found that neither serine, nor its O-phospho and its O-sulpho derivative could serve as donor of 
the alanyl moiety. Attempts are reported to prepare above-mentioned ß-substituted alanines 
biomimetically using a pyridoxal-5'-phosphate (PLP) catalyzed chemical reaction between O-
acetyl L-serine and the heterocycle in the presence of metal ions, especially gallium ions. The 
yields are usually low-to-very low; 30% yields or more are mentioned for ß-(pyrazol-l-yl)-alanine 
(40-45%), ß-(5-methylisoxazolin-3-on-2-yl)alanine (0.15%) and ß-(3-amino-l,2,4-triazol-l-
yDalanine (30-35%)1. 
Due to our interest in the use of enzymes in synthetic procedures we turned our attention to 
the preparation of the ß-purinyl-L-alanine derivative, called L-lupinic acid la, which is isolated 
from lupinus angustifolius 2 and which is a principal metabolite of the phytohormone trans-
zeatine (E-lb), being one of the most effective natural stimulants of plant cell division (see fig. 
VIII.l). 
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/ \ 
CH2 CH3 
1a: R = CH2CH(NH2) CO2H 
1b:R = H 
- Fig. VIII.1 
The chemical synthesis of a racemic mixture of D,L-la has been described2. However, pure L-
lupinic acid (L-la) and D-lupinic acid (D-la) have never been prepared. Only the enzymatic 
formation of L-la from fnws-zeatin (E-lb) and O-acetyl L-serine, using as enzyme source extracts 
of Lupinus seedlings has been reported. Attempts to prepare L-la by a PLP-catalyzed reaction 
between E-lb and O-acetyl-L-serine with little succes (yield about 1,5%)3. 
For the production of optically pure D- and L-amino acids enzymatic resolution methods have 
proven to be powerful tools. The enzymatic resolution process developed by DSM (Dutch State 
Mines), based on the stereospecific hydrolysis of amino acid amides by using the L-specific 
aminopeptidase from Pseudomonas putida has found wide application4. We wanted to study if 
this enzyme would also be useful for the preparation of L-lupinic acid (together with D-lupinic 
acid amide) from DL-lupinic acid amide; from D-lupinic acid amide D-lupinic acid could be 
obtained. 
RESULTS AND DISCUSSION 
The strategy we have adopted for the synthesis of L-lupinic acid (L-la) and D-lupinic acid (D-la) 
consists of the following steps i) the synthesis of frans-zeatine (E-lb) ii) the synthesis of 
trifluoroacetylaminoacrylate 4, iii) coupling of 4 with E-lb at position 9 of the purine ring into 
D,L-5, iv) removal of the protecting trifluoroacetyl group and conversion of the ester group into 
the amide function affording D,L-lupinic acid amide (D,L-6), v) enzymatic stereospecific 
hydrolysis of DL-6 with L-specific aminopeptidase into L-lupinic acid (L-la) and D-lupinic acid 
amide (D-6), vi) the chemical conversion of D-Lupinic acid amide (D-6) under mild acid 
condition into D-Lupinic acid (D-la) (see scheme VIII.1). 
Our synthesis of irans-zeatin (E-lb) is a modification of two syntheses, being already reported5'6. 
In our work N-(4-acetoxy-3-methyl-E-but-2-enyl) phthalimide (E-2), being prepared by a 
procedure described before, was converted in a one-pot reaction into 4-hydroxy-3-methyl-E-but-
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2-enylamine (E-3) by treatment with 85% aqueous hydrazine to remove the phthaloyl group and 
subsequent heating with hydrochloric acid to hydrolyse the acetate group (yield 85%). Coupling 
of E-3 with 6-chloropurine (reagent A) in refluxing butanol in the presence of triethylamine gave 
fraws-zeatine (E-lb). The coupling of E-lb with methyl trifluoroacetylamino acrylate (reagent B: 4) 
into ß-[6-(4-hydroxy-3-methyl-E-but-2-enylamino)purin-9-yl]-N-trifluoro-acetylalanine methyl 
ester (D,L-5) requires difficult conditions7. Optimum yields (about 80%) were obtained when a 
solution of an equimolar amount of 4 and E-lb in dimethyl sulphoxide, containing potassium 
bicarbonate was stirred for three days at 25°C. Using the stronger base potassium carbonate 
instead of potassium bicarbonate resulted in lower yields of D,L-5. Removal of the protecting N-
trifluoroacetylgroup in D,L-5 and conversion of the ester group into a carboxylic amide function 
was realized by heating a solution of D,L-5 in butanol, being saturated with ammonia, for three 
days at 35°C in a sealed tube. The yield of the racemic mixture of D,L-lupinic acid amide (D,L-6) 
amounted to 85%. 
The resolution was succesfully achieved by using L-aminopeptidase from Pseudomonas putida, 
which converts L-carbonamide 6 into the corresponding L-lupinic acid L-la, but does not 
hydrolyse D-carbonamide 6. By use of a strong basic ion-exchange column the L-lupinic acid (L-
la) could be easily separated from the D-lupinic acid amide (D-6). D-Lupinic acid amide (D-6) was 
treated with 6N hydrochloric acid at room temperature to obtain D-Lupinic acid (D-la). 
The optical purities of L-la and D-6 were established by reacting each of these compounds as 
well as the racemic mixture of D,L-la (obtained by treatment of a solution of D,L-5 in dioxane-
water with aqueous sodium hydroxide at room temperature) with pure S-2-chloropropionyl 
chloride8. This reagent reacts with D,L-a-amino acids into the corresponding diastereoisomeric 
N-(S-2-chloropropionyl) derivatives. In the 'H-NMR spectra of these D,L derivatives the 
chemical shift for the methyl doublet of the CH3-CHCI moiety is found to be different for both 
diastereoisomers. When this technique is applied to D,L-la we observed two methyl doublets of 
the CH3-CHCI part at 1,53 and 1,56 ppm. However, the XH-NMR spectrum of the N-(S-2-
chloropropionyl) derivative of L-la exhibits only a CH3-CHCI methyl doublet at 1,53 ppm; the 
N(S-2-chloropropionyl) derivative of D-6 only gave the methyl doublet at 1,56 ppm. From these 
results it can be unequivocally concluded that the enzymatic separation was succesful and that L-
lupinic acid has been obtained with high optical purity (e.e > 95%). Acid hydrolysis of D-6 gave 
optically pure D-lupinic acid (D-la). 
EXPERIMENTAL 
General methods and materials 
Schleicher and Schul DC Fertigfolien F1500 LS 254 were used for TLC, the following solvent 
systems were used: System A (chloroform/methanol, 90:10, v/v), system B (chloroform/ 
methanol, 86:14, v/v), system C (chloroform/methanol, 80:20, v/v), system D (chloroform/ 
methanol/concentrated ammonium hydroxide, 60:40:20, v/v). ïH-NMR-spectra were measured 
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using a Hitachi Prekin-Elmer R-248 or a Varian EM 390 spectrometer. 13C-NMR-spectra were 
measured at 75.460 MHz using a Bruker CXP 300 spectrometer; proton noise decoupling was 
used. Mass-spectra were recorded on an AEI MS 902 instrument, equiped with a VG/ZAB 
console. Ultraviolet spectra were determined using a Beckmann Du-7 spectrometer. Melting 
points were determined on a Kofler hot stage equipped with a microscope and a polarizer. They 
are uncorrected. Optical rotations were measured at 20° C with a Perkin Elmer 141 Polarimeter. 
Dimethylsulphoxide was dried by stirring with CaH2 for 16 h, then distilled under reduced 
pressure and stored over molecular sieves 4A. Triethylamine was dried by refluxing with CaH2 
for 16 h, then distilled and stored over molecular sieves 4A. n-Butanol (analyzed grade, Baker) 
was used without further purification. n-Butanolic ammonia was prepared by passing dry (KOH) 
ammonia gas through butanol at -20°C until saturation. 
Synthesis of 4-hydroxy-3-methyl-E-but-2-enylamine (E-3) 
A mixture of N-(4-acetoxy-3-methyl-E-but-2-enyl)phthalimide (E-2) (9.46, 40.7 mmol), 85% 
aqueous hydrazine hydrate solution (2.44 ml, 40.8 mmol) and methanol (100 ml) was refluxed for 
1 h with stirring. TLC-analysis (system A) indicated that under these conditions complete 
conversion of the starting material took place into a product having Rf=0. After cooling of the 
solution, water (25 ml) and concentrated hydrochloric acid (25 ml) were added and the reaction 
mixture was heated under reflux for 1 h. After cooling to 0°C phthalylhydrazide precipitated, 
which was removed by filtration; the filtrate was evaporated at 30°C in a rotary evaporator. The 
residue was dissolved in water (20 ml) and the insoluble material was removed by filtration; the 
filtrate was made alkaline untill pH of 10 with 4N aqueous sodium hydroxide solution. This 
solution was continuously extracted with chloroform. The organic extract was, after drying on 
MgSC>4 evaporated to give the aminoalcohol E-3. Yield 3.5 g (85%), oil. ïH-NMR-spectral data are 
identical with those reported in the literature5. 
Synthesis of trans-zeatin (E-lb) 
A mixture of aminoalcohol E-3 (3.5 g, 34.7 mmol), 6-chloropurine (5.02 gram, 32.7 mmol), 
anhydrous triethylamine (4.7 ml) and n-butanol (150 ml) was boiled under reflux for 3 h. TLC-
analysis (system B) indicated that the conversion of the starting material was complete. The 
solvent was removed and the residue recrystallized twice, first from water, then from ethanol, to 
give frans-zeatin as white crystals. Yield 5.73 g (80%), m.p. 208-209°C, m.p. lit. 209-210°C, ^ - N M R 
and 13C-NMR spectral data were identical as described9-10. 
Synthesis of D,L-ß-f6-(4-hydroxy-3-methyl-E-but-2-enylamino)purin-9-yll-N-trifluoroacetylala-
nine methylester (D,L-5) 
A mixture of frans-zeatin, (E-lb) (5.7 g, 26,2 mmol), methyl 2-trifluoro-acetylaminoacrylate2 (5.2 
g, 26,2 mmol) dry dimethylsulphoxide (25 ml) and KHCO3 (150 mg) was stirred for 3 days at 20°C, 
TLC-analysis (system C) indicated that then the reaction was complete. The reaction mixture was 
poured into water (50 ml), extracted with chloroform (3x100 ml) and the combined organic 
extracts were dried with MgSC>4. The organic layer was concentrated to an oil, which was 
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chromatographed on a column of silica gel (230-400 mesh ASTM). Elution with chloroform/ 
methanol (100:0 -» 98:2, v/v) gave after evaporation pure D,L-5 as an oil. Yield 8.16 g (75%), 
Rf=0,8 (system C) 
1H-NMR (CDC13): 6 1.70, s, 3H, CH3; 3.92, s, 3H, COOCH3; 4.10, s, 2H, CH20; 4.30, t, J=3.8 Hz, 2H, 
CH2N; 4.8-5.2, m, 3H, Ca-H, 2x Cß-H; 5.57, t, ]=6.2 Hz, 1H, CH=C; 6.75, t, J=3,8 Hz, 1H, NHCH7; 7.81, 
s, 1H, H-2; 8.42, s, 1H, H-8; 10.20, m, 1H, NHCOCF3; J3C-NMR (CDCI3): 5 167.73, ÇOOCH3); 157.57, 
q, Jc-F=39 Hz, ÇOCF3; 154.48, C6; 152.70, C2; 148.68, Q ; 139.96, C8; 138.90, CH3C=C; 119.82, C_H=C; 
119.15, C5; 115.40, q, Jc-F=287 Hz, CF3; 66.90, CH2OH; 52.94, OCH3; 52.80, C^ 44.23, NHCH2; 38.3, Cp, 
13.52, CH3; FD/MS: m/z: 416, [M+]; 396, [(M-HF)+]; 385, [(M-CH30)+]; 357, [(M-C2H302)+]. 
Synthesis of D,L-ß-[6-(4-hydroxy-3-methyl-E-but-2-enylamino)purin-9-ynalanine carbonamide 
(P.L-6) 
The racemic mixture D,L-5 (6.74 g, 16.2 mmol) was dissolved in dry n-butanol (150 ml), which 
was saturated with NH3; the solution was heated at 30°C for 3 days in a sealed tube. TLC-analysis 
(system C ) showed the complete absence of D,L-5 and formation of a new compound with 
Rf=0.23. The solution was evaporated to an oil, which was crystallized from methanol to give 
D,L-6 as white crystals. Yield 4.2 g (85%). mp. 190-192°C, [Rf=0.23 (system C, Rf=0.86 (system D). 
1H-NMR (DMSOd6): 5 1.73, s, 3H, CH3; 3.66, dd, J=8.1 Hz and 5.2 Hz, 1H, Ca-H; 3.84, d,J =5.7 Hz, 
CH20; 4.17, m, 3H, NH-CH? and Cß-H; 4.45, dd, J=13.9 Hz and 5.2 Hz, 1H, Cß-H; 4.79, t, J=5.7 Hz, 
1H, OH; 5.59, t, J=6.1 Hz, 1H, CH=C; 7.22 and 7.55, br s, 2H, CONH2; 7.85, br s, 1H, NHCH2; 8.07, s, 
1H, H-2; 8.27, s, 1H, H-8; 13C-NMR (D20): 5 176.55, C=0; 154.46, C6; 152.75, C2; 148.39, C4; 141.99, C8; 
138.75, CH3£=C; 121.11, CH=C: 118.70, C5; 66.89, CH20, 54.19, Ca; 47.18, NH CH2, 38.63, Cß, 13.28, 
CH3; FD/MS: m/z 306, [(M+H)+]; 305 [M+]; 219 [(M-C3H7N20)+]. 
UV-spectra showed A.max at the pH of 3, of 6 and of 11 at 266.3, 269 and 270 nm, respectively, being 
characteristic of (N6,N9)-disubstituted adenines11. 
Synthesis of D,L-ß-f6-(4-hydroxy-3-methyl-E-but-2-enylamino)purin-9-yllalanine. (D.L-la) 
A stirred solution of the ester D,L-5 (140 mg, 0.34 mmol) in dioxane (10 ml) and H 2 0 (5 ml) was 
treated with 1 N NaOH for 4h. The pH of the solution changed from 6 to 10, after 4h at 20°C. TLC-
analysis (system D) indicated complete conversion of the starting material. The solution was 
percolated through a column (50 ml) of the anion exchange resin Dowex AC-1-X8 (OH--form); 
the column was washed with water (150 ml) and then eluted with 0.1 N HCl. The eluate was 
passed directly through a column (60 ml) of cation exchange resin Dowex AC-50W-X8 (H+-form). 
Then the column was washed with water and eluted with ammonia (IN). This eluate was 
evaporated to dryness and the residue was crystallized from ethanol/water. 
Yield: (±)-Lupinic acid (D,L-la): 128 mg (70%), m.p. 215-216°C; lit.1: 216-217°C, [Rf=0 (system C), 
Rf=0.74 (system D)]. 
!H-NMR (DMSO-d6 ): 6 1.72, s, 3H, CH3; 3.83, s, 2H, CH20; 3.88, dd, J=4.3 Hz and 8.2 Hz, 1H, Ca-H; 
4.17, br s, 2H, NHCH7; 4.56-4.70, m, 2H, 2x Cp-H; 4.88, br s, 1H, CH7-OH; 5.57, t, J=5.9 Hz, 1H, CH=C; 
7.92, br s, 1H NH-CH7; 8.17, s, 1H, H-2; 8.27, s, 1H, H-8; '3C-NMR (DMSO-d6): 6 171.08, C=0; 155.69, 
C6; 154.10, C2; 150.16, C4; 143,19, C8,139.99, CH3£=C; 121.83, £H=C; 120.02, C5; 67.72, CH20; 55.89, 
72 
C«; 45.91, NHCH2; 14.84, CH3; FD/MS: m/z: 306 [M+]; 262 [(M-C02)+]; 218[(M-C3H602N)+]. 
Synthesis of L-ß-f6-(4-hydroxy-3-methyl-E-but-2-enyl amino)purine-9-yllalanine (L-lupinic acid, 
L-la) 
The amide of D,L-lupinic acid (D,L-6) (2.0 gram, 4.93 mmol) was dissolved in 40 ml water and 
treated for 20 h at 40°C at pH=1012 with aminopeptidase from Pseudomonas putida (4) (0.4 g of 
crude cells containing about 1% of active enzyme). The L-amino acid (L-la) was separated from 
the D-amide (D-6) by the use of a strong basic ion-exchange column (see previous sections). 
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Elution with 2N acetic acid gives L-lupinic acid (L-la) 0.85 g, Rf=0.74 (system D), [cc]D = -24.5 (c=l, 
20 
H2O) and the unreacted D-lupinic acid amide (D-6) 0.78 g, Rf=0.86 (system D),[a]D = -99 (c=l, 
H2O). iH-NMR and 13C-NMR and mass spectrometric data of compound L-la and D-6 are 
identical with those of D,L-la and D.L-6, respectively. 
Synthesis of D-ß-[6-(4-hydroxy-3-methyl-E-but-2-enylamino)purine-9-yl]alanine (D-Lupinic acid 
D-la) 
A solution of the unreacted D-Lupinic acid amide (D-6) (120 mg, 0.40 mmol) in H2O (5 ml) was 
treated with 6N HCl (2 ml). After one week at 20°C, TLC analysis (system D) showed complete 
conversion op the starting material with Rf=0.86 into the product D-la, Rf=0.74. The reaction 
solution was neutralized with NaOH (4N) to pH=7.5. The reaction solution was concentrated to a 
small volume (1 ml) and applied to silanized silica gel RP18. The column was eluted with water 
applying a methanol gradient (0—>60%), which gave after evaporation D-la as a white solid. 
20 
Yield 95 mg (77%), Rf=0.78, [cc]D = +26.0 (c=l, H20). 'H-NMR, 13C-NMR and mass spectrometric 
data of D-la are identical with those of D,L-la. 
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CHAPTER IX 
GENERAL DISCUSSION 
During the investigations described in this thesis considerable progress has been made in the 
synthetic development of two classes of cytokinins, namely a. the synthesis of phosphorylated 
cytokinins (1-15) and b. the synthesis of alanylated cytokinins (16) (see fig. IX.1 ). 
A. THE SYNTHESIS OF PHOSPHORYLATED CYTOKININS 
The introduction of the phosphate group and modified phosphate groups in naturally 
occurring cytokinins is the major subject of this thesis. 
The strategy we have adopted for the synthesis of these cytokinins is : 
1. The preparation of properly protected cytokinins (see fig. IX.2) which serve as starting material 
for the synthesis of phosphorylated cytokinins. 
2. the effective phosphorylation of the free hydroxyl groups in these protected cytokinins 
3. the removal of all protective groups. 
In our strategy dealing with the preparation of properly protected cytokinins, we used the base-
labile acetyl group for the protection of the allylic hydroxy function, the acid-labile 
methoxymethylidene group for the protection of the 2'-OH and 3'-OH function, the acid-base-
labile-tert-butyldimethylsilyl (TBDMS) group for the protection of the 5'-OH-function and the 
acid-labile tetrahydropyranyl (THP) for the protection of N9-position at the purine. 
All these protective groups were relatively easy to introduce and stable under all conditions 
required in the synthesis of the phosphorylated products. Furthermore, the removal of these 
protective groups caused no instability of the products. 
The use of these protective groups was necessary for selective introduction of the phosphate 
groups at the desired allylic position, and/or at the 5'-position in the ribose ring. Moreover, by 
the use of protective groups side reactions are avoided during the phosphorylation. 
The second step in our strategy deals with the effective phosphorylation of the free hydroxy 
groups of the properly protected cytokinins. 
There are many phosphorylating agents described in the literature for the introduction of 
phosphorus containing groups on primary hydroxy groups present in naturally occurring 
compounds. A good and concise review of phosphorylating reagents, which covers the literature 
up to 1980, was presented by Scheit1. An effective bifunctional phosphorylating reagent, N-
morpholino-0,0-bis[(6-trifluormethyl)-benzotriazolyl]phosphate 22 was found to be suitable for 
the preparation of 5'-monophosphates of nucleosides 2 . We applied this phosphorylating 
reagent for the synthesis of cytokinin-5'-monophosphates 6 and 7 (see scheme IX.1). Treatment of 
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the properly protected cytokinins 21 and 18 with 22 yielding the phosphate triesters 23 and 24, 
respectively and cleavage of all protective groups gave the phosphorylated cytokinins 6 and 7, 
respectively. The introduction of the phosphate group and its modification at the allylic position 
is difficult, because allylic phosphates are good leaving groups. There are two methods for the 
chemical phosphorylation of an allylic hydroxy group. One method3 (see scheme IX.2) is based on 
the activation of the allylic hydroxy group on 25 with trichloroacetonitril in the presence of 
sodium hydride to give intermediate 26. Replacement of the trichloroacetamide group by ortho-
phosphoric acid affords the monophosphates 27 and 28. The formation of the rearrangement 
product 27, however, makes the isolation of 28 rather laborious. The formation of the two 
products 27 and 28 suggests that the allylic substrate 26 undergoes nucleophilic substitution by an 
SNi mechanism, yielding the resonance stabilized allylic carbocation (see scheme IX.3). C4 and C2 
each carrying a partial positive charge are attacked by the nucleophilic H3PO4 to give the normal 
product 28 and the rearranged product 27. 
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The second method 4 for the synthesis of allylic phosphates, which is illustrated in scheme 
IX.2, is based on conversion of the allylic hydroxy g roup of geraniol 25 with O-
phenylphosphorochloridate into 29, which after hydrolysis yields 30. However, deblocking of the 
in termedia te phosphodies te r 30 with lead(IV)acetate, gives rise to the formation of many 
coloured by-products. 
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The above-mentioned problems induced us to look for new phosphorylating agents in order 
to achieve a succesful synthesis of cytokinins, which contain allylic phosphates. Preliminary 
experiments to introduce a phosphate group in the allylic position of alcohol 31 (see scheme IX.4) 
by treatment with the bifunctional phosphorylating reagent 22 in the presence of a base gave 
however the non-phosphorus containing compound 33. This suggested that after the allylic 
alcohol of 31 was phosphorylated, this group is easily replaced due to the good leaving character 
of the allylic phosphate triester group in 32, by the nucleophile trifluoromethylbenzotriazolyl 
anion, present in the solution. This problem was circumvented by using the phosphitetriester 
approach, which is illustrated in scheme IX.5. This methodology was not only suitable for the 
introduction of the phosphate group on the allylic alcohol, but was also suitable for the 
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introduction of methylphosphate and thiophosphate. This method consists of treatment of the 
appropriately protected allylic alcohol with the phoshitylating reagent salicyl chlorophosphite, 
yielding intermediate 35, which is easily hydrolysed into the phosphonate monoester 36. The 
phosphonate monoester 36 was silylated with N,0-bis(trimethylsilyl)-acetamide to give 
intermediate 37. The silylation step is necessary5 to transform the phosphate esters into the 
trivalent form of bis(silyl)phosphites 37, which are more susceptible to oxidation or sulfurization 
than the tetracoordinated species of type 36. Reaction of 37 with powdered sulfur gave after 
hydrolysis the thiophosphate 38. Reaction of 37 with 2,2'-dipyridyldisulfide gave intermediate 
39, which on hydrolysis with water gave the monophosphate 40. Methanolysis of 39 with dry 
methanol gave methylphosphate 41. This above mentioned phosphitetriester approach appeared 
to be very succesful in the synthesis of cytokinin derivatives with allylic phosphor containing 
groups. Thus, the phosphitylation of the free hydroxy groups in the properly protected cytokinins 
17,19 and 20 (see fig. IX.2) with salicyl chlorophosphite gave the corresponding phosphate 
monoester. This phosphate monoester was converted into the corresponding phosphate, 
methylphosphate, and thiophosphate; after cleavage of the protective groups THP, 
methoxymethylidene and TBDMS under mild acidic conditions the phosphorus derivatives of 
cytokinins were formed6'7'8 
Finally, we will discuss the synthesis of the allylic pyrophosphate of frans-zeatin. Two 
methods are discribed in the literature for the synthesis of the allylic pyrophosphate. The first 
procedure9 (see scheme IX.6) is based on treatment of the allylic alcohol with trichloroacetonitril 
and orthomonophosphate. It gives, however, a mixture of organic and inorganic mono-, di- and 
triphosphate. The yield of the desired product rarely exceeds 30% and further losses are 
encountered during purification. In addition, the procedure becomes difficult to manage if more 
than 50 mg of the product is desired. 
The second procedure10 described in the literature is based on activation of an allylic alcohol 
by conversion into an allylic halide (see scheme IX.7). The activated intermediates are treated 
with tris-(tetra-n-butylammonium)hydrogenpyrophosphate to obtain the allylic pyrophosphate 
ester. In order to examine this above mentioned possibility for the preparation of the allylic 
pyrophosphate of frans-zeatin 3, we made attempts to halogenate the allylic hydroxy group in 
trans zeatin by using either phosphorus tribromide or N-chlorosuccinimide. Both attempts were 
unsuccessful since they gave rise to the formation of a lot of coloured and unidentified products. 
A succesful synthesis of allylic pyrophosphate 3 was realized by the phosphitylation of the 
allylic hydroxy group in 42 with salicyl chlorophosphite to give the allylic phosphonate 43 
(scheme IX.8). Cleavage of the tetrahydropyranyl groups under mild acidic conditions gave 44. 
The allylic phosphonate 44 was converted into the corresponding phosphoromorpholidate 47, 
which was treated with mono-(tri-n-butylammonium)phosphate to give the allylic 
pyrophosphate 3. 
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B. THE SYNTHESIS OF ALANYLATED CYTOKININS. 
the synthesis of the optically active N9-alanylzeatin 
(D and L lupinic acid) 
The chemical synthesis of a racemic mixture of D,L-lupinic acid is described in the literature11. 
Pure L-lupinic acid and D-lupinic acid have never been prepared; only enzymatic formation of L-
16 from trans zeatin 49 (see fig. IX.3) and O-acetyl-L-serine, using as enzym source extracts of 
lupinus seedling has been reported12. Attempts13 to prepare L-16 (see fig. IX.3) by a pyridoxal 5'-
phosphate (PLP)-catalyzed reaction between 49 and O-acetyl-L-serine have met with little success 
(yield 1.5%). 
H CH2OH 
\ / 
/ \ 
CH2 CH3 
16, R = CH2CH(NH2)COOH 
49, R = H 
Fig IX.3 
For the production of optically pure D- and L-amino acids, enzymatic resolution methods 
have proven to be powerful tools. The enzymatic resolution process developed by DSM14, based 
on the stereospecific hydrolysis of aminoacid amides by using the L-specific aminopeptidase from 
Pseudomonas Putida, has found wide application. 
In order to examine the above described methodology as being suitable for the synthesis of L-
lupinic acid L-16 and D-lupinic acide D-16 we developed the following strategy (see scheme IX.9): 
1. the synthesis of racemic D,L-amino acid amide D,L-51. 
2. the stereospecific hydrolysis of D,L-51 by using the L-specific aminopeptidase to afford L-acid 
L-16 and D-amide D-51. 
3. the chemical conversion of the D-51 into D-acid D-16. 
The synthesis of D,L-lupinic aminoacid amide D,L-51 (see scheme IX.9) was achieved by i) 
coupling of the aminoalcohol reagent A with 6-chloropurine 48 ii) coupling of 49 with 
methyltrifluoracetylaminoacrylate (reagent B) to afford D,L-50 iii) treatment of D,L-50 with NH3. 
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The second part of our strategy dealing with the enzymatic stereospecific hydrolysis of the 
racemate D,L-51 with L-aminopeptidase from Pseudomonas Putida, gave L-lupinic acid L-52 the 
amide D-51, both in an optical purity of more than 95%. The optical purity of both enantiomeric 
compounds was determined by means of 'H-NMR spectroscopy using the chiral shift reagent S-
2-chloropropionylchloride (see chapter VIII). The unreacted D-51 was hydrolyzed under mild 
acid conditions to afford the optically pure D-Lupinic acid D-16. 
CONCLUSION 
In this thesis we described the synthesis of sixteen phosphorylated cytokinins and two 
alanylated cytokinins. 
The succesful synthesis of phosphorylated derivatives was realized by using an efficient way of 
preparing properly protected cytokinins and new phosphorylation methods. This combination of 
methods leads to a fast and reliable procedure for the preparation of phosphorylated cytokinins 
in satisfactory yields. 
The results of the synthesis of optically pure alanylated cytokinins lead unequivocally to the 
conclusion that the enzymatic separation by Pseudomonas Putida was succesful. 
In this way we introduced a new, efficient method for the synthesis of optically active D- and 
L-lupinic acid. Furthermore, we believe that this method is also suitable for the synthesis of 
many optically active aminoacids with a heterocyclic ring on the ß-position. As we have 
mentioned previously, this synthetic study was part of a program between our laboratory and the 
Centre of Agricultural and Biological Research at Wageningen. This centre uses the produced 
phosphorylated and alanylated compounds for biological research. Some of these results have 
been published in an article: "Formation of zeatin allylic phosphate by the microsomal fractions 
of bulb disks of Iris x hollandica Tub. and tubers of Helianthus tuberosus L". The phosphorylated 
cytokinins also attracted the attention of the National Cancer Institute in the U.S.A. for clinical 
research. We reported above (see chapter I, page 2) that cytokinins have been employed as 
potential anticancer agents in clinical trials. One of the phosphorylated compounds is being 
tested at this moment in the anticancer screening program of this institute. 
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SUMMARY 
New approaches are described in this thesis towards the syntheses of phosphorylated and 
alanylated cytokinins. 
In chapter I a general picture of the stucture of cytokinins, their occurence in nature, their 
biological synthesis, their effects on plants and their chemical synthesis is described. 
A literature survey of the synthesis of phosphorylated and alanylated cytokinins is given in 
chapter II. Furthermore, this chapter contains a short introduction of our approach towards the 
synthesis of phosphorylated and alanylated cytokinins. 
In chapter III the phosphorylation of allylic hydroxy groups via phosphite intermediates is 
described. A new method is introduced for the introduction of a phosphate group at the allylic 
position. This phosphite triester approach is based on the phosphitylation of the allylic alcohol 
with salicyl chlorophosphite, followed by the oxidation of the allylic phosphonate monoester to 
the corresponding phosphate monoester. 
The synthesis of allylic phosphor derivatives of trans-zeatin is described in chapter IV. We 
showed in this chapter that the phosphite triester approach is not only suitable for the synthesis 
of the allylic phosphate of the cytokinin frans-zeatin, but is also suitable for the synthesis of the 
allylic thiophosphate and the methylphosphate of frans-zeatin. 
Chapter V deals with a convenient new synthesis of the allylic pyrophosphate of frans-zeatin. 
This method is based on the conversion of the allylic phosphonate of frans-zeatin into the 
corresponding allylic phosphoromorpholidate, which after treatment with the mono(tri-n-
butylammonium) phosphate gave the allylic pyrophosphate of frans-zeatin. 
In chapter VI the synthesis of the phosphate derivatives of the ribosyl zeatin and N6-(A2-
isopentenyl)adenosine is described. 
Two approaches were used for the synthesis of these cytokinin phosphates. A phosphor 
triester approach which is based on the use of the bifunctional phosphorylating reagent N-
morpholino-0,0-bis[(6-trifluormethyl)benzotriazolyl]phosphate, for the preparation of ribosyl 
zeatin 5'-phosphate and N6-(isopentenyl)adenosine 5'-phosphate, whereas phosphite triester 
approach, which is based on the use of the monofunctional phosphitylation reagent 
salicylchlorophosphite, was applied to the synthesis of ribosyl zeatin allylic phosphate and ribosyl 
zeatin diphosphate. 
In chapter VII the syntheses of phosphor derivatives of ribosyl zeatin are described. The 
phosphite triester approach was also used here. Phosphitylation of the properly protected zeatin 
ribosyl derivatives by using salicylchlorophosphite gave the corresponding phosphonates which 
could be converted into the corresponding phosphate, methylphosphate and thiophosphate. 
After cleavage of the protective groups the phosphorderivatives of ribosyl zeatin are obtained. 
In chapter VIII the synthesis of alanylated cytokinins is described, namely the synthesis of 
optically active L-lupinic acid and D-lupinic acid. These were obtained in an optical purity of 
more than 95%, by enantioselective hydrolysis of a racemic mixture of the amide of D,L-lupinic 
acid with aminopeptidase from Pseudomonas Putida. Hydrolysis of D-lupinic acid amide gave D-
lupinic acid. 
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SAMENVATTING 
In dit proefschrift zijn nieuwe methodes voor de synthese van gefosforyleerde en 
gealanyleerde cytokininen beschreven. 
In hoofdstuk I wordt de struktuur van cytokininen, hun voorkomen in de natuur, biologische 
synthese, effekten in planten en hun chemische synthese in het algemeen beschreven. Een 
overzicht van de synthese van gefosforyleerde en gealanyleerde cytokininen, beschreven in de 
literatuur, wordt gegeven in hoofdstuk II. Dit hoofdstuk bevat verder een korte inleiding tot 
onze methode voor de synthese van gefosforyleerde en gealanyleerde cytokininen. 
In hoofdstuk III wordt de fosforylering van allylische hydroxy groepen via fosfiet-
intermediairen beschreven. Een nieuwe methode werd geïntroduceerd voor de invoering van 
de fosfaat groep op het allylisch alcohol. Deze fosfiet triester methode is gebaseerd op de 
fosfietylering van de allylische alcohol met salicylchlorofosfiet, gevolgd door oxidatie van de 
allylische fosfonaat monoester tot de overeenkomstige fosfaat monoester. 
De synthese van allylische fosfor derivaten van frans-zeatin wordt beschreven in hoofdstuk 
IV. In dit hoofdstuk laten we zien dat de bovengenoemde fosfiet triester methode niet alleen 
geschikt is voor de synthese van het allylisch fosfaat van frans-zeatin, maar ook voor de synthese 
van het allylisch thiofosfaat en het methylfosfaat van frans-zeatin. 
In hoofdstuk V wordt een geschikte nieuwe methode voor de synthese van het allylische 
pyrofosfaat van frans-zeatin behandeld. Deze methode is gebaseerd op de omzetting van het 
allylisch fosfonaat van frans-zeatin in het overeenkomstig allylisch fosformorfolidate, hetgeen 
na behandeling niet mono(tri-n-butylammonium)fosfaat het allylisch pyrofosfaat van trans-
zeatin geeft. In hoofdstuk VI beschrijven we de synthese van de fosfaat derivaten van ribosyl 
zeatine en N6-(A2-isopentenyl)adenosine. Twee methodes worden gebruikt voor de synthese van 
deze cytokinine fosfaten. De fosfaat triester methode die gebaseerd is op het gebruik van het 
bifunctionele fosforylerende reagens N-morfolino-0,0-bis[(6-trifluormethyl)benzotriazolyl]-
fosfaat, werd toegepast voor de synthese van het ribosyl zeatine 5'-fosfaat en het N6-(A2-
isopentenyl)adenosine 5'-fosfaat, terwijl de fosfor triester methode, gebaseerd op het gebruik van 
het monofunctionele fosfietylerende reagens salicylchlorofosfiet, toegepast werd voor de 
synthese van het ribosyl zeatine difosfaat. 
In hoofdstuk VII wordt de synthese van fosforderivaten van het cytokinine ribosyl zeatine 
beschreven. De fosfor triester methode werd ook hier gebruikt. Fosfietylering van de op de juiste 
manier beschermde ribosyl zeatine derivaten met salicylchlorofosfiet gaf de overeenkomstige 
fosfonaten, die konden worden omgezet in het overeenkomstige fosfaat, methylfosfaat en 
thiofosfaat. Na afsplitsing van de beschermende groepen werden de fosforderivaten van ribosyl 
zeatine gevormd. 
In hoofdstuk VIII wordt de synthese van gealanyleerde cytokinine beschreven; namelijk die 
van optisch aktief L-lupine zuur en D-lupine zuur. Beiden werden verkregen met een optische 
zuiverheid van meer dan 95%, door enantioselectieve hydrolyse van het racemische D,L-lupine 
zuuramide met aminopeptidase van Pseudomonas Putida. Hydrolyse van D-lupine zuur amide 
gaf D-lupine zuur. 
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